{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":57,"total_is_capped":false,"direct_labels_cover":4,"predictions_cover":57,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"4ceb0606b211","filters":{"venue":"HIV Clinical Trials"}},"results":[{"id":"W1965948300","doi":"10.1310/hct1104-186","title":"Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad<sup>®</sup>Efficacy and Safety (SMiLES)","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS oral health manifestations","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tolerability; Miconazole; Clotrimazole; Buccal administration; Clinical trial; Randomized controlled trial; Adverse effect; Internal medicine; Pharmacology; Antifungal; Dermatology","retraction":null,"screen_n_in":null,"score":{"opus":0.2931300087889962,"gpt":0.5013441931525906,"spread":0.2082141843635944,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008979245,0.0004440513,0.00506248,0.0002420276,0.0001957413,0.00003014073,0.0002240819,0.0003294269,0.00008437647],"category_scores_gemma":[0.002368485,0.0002711102,0.0006968515,0.0002594338,0.0009703972,0.0001339026,0.0000769407,0.000411854,0.000002411609],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003763202,"about_ca_system_score_gemma":0.0004124122,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007763347,"about_ca_topic_score_gemma":0.0004044994,"domain_scores_codex":[0.9915392,0.001755872,0.005142385,0.0006542102,0.0004731055,0.0004352686],"domain_scores_gemma":[0.9633197,0.03330455,0.001813624,0.0007049746,0.0004516265,0.0004055093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9756451,0.0115711,0.003083709,0.000239441,0.001458831,0.000003587021,0.003821426,0.00004915842,0.0005398603,0.0003424052,0.0005396257,0.00270579],"study_design_scores_gemma":[0.9754049,0.00924892,0.001858917,0.0001080902,0.003800498,0.000006017072,0.002569258,0.002179336,0.001651664,0.00002711578,0.002937192,0.0002081083],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751241,0.0008441923,0.00009643564,0.001035749,0.000495479,0.0217026,0.0005736942,0.00002632244,0.0001014749],"genre_scores_gemma":[0.9947226,0.001682933,0.001236415,0.00007807787,0.0008807799,0.0009389549,0.0001544922,0.00003524864,0.0002704978],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03154868,"threshold_uncertainty_score":0.9999741,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2411587754","doi":"10.1080/15284336.2016.1184827","title":"Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot Trials","year":2016,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Maple Leaf Medical Clinic; University of Toronto; Public Health Ontario; University Health Network","funders":"Canadian Institutes of Health Research; Ontario HIV Treatment Network","keywords":"Medicine; Cart; Immune system; Inflammation; Systemic inflammation; Immunology; Tolerability; Probiotic; Population; Placebo; Gut flora; Internal medicine; Adverse effect; Biology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1655538968730954,"gpt":0.4415779428807052,"spread":0.2760240460076098,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02318679,0.000229071,0.0009851016,0.00007371609,0.0002203595,0.00006726289,0.0001393403,0.0001800341,0.000002995938],"category_scores_gemma":[0.006936357,0.0001328488,0.0001142999,0.0001187841,0.0001079411,0.00001913865,0.00003672383,0.00010026,9.334257e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004622526,"about_ca_system_score_gemma":0.000557796,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003039076,"about_ca_topic_score_gemma":0.001286965,"domain_scores_codex":[0.9947914,0.001906508,0.00230696,0.0005614181,0.00009370383,0.0003400314],"domain_scores_gemma":[0.9942526,0.004060485,0.001069311,0.0003371944,0.000174532,0.0001059383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004102728,0.0003662001,0.002252068,0.0004112347,0.0001747079,1.165249e-7,0.001174123,0.00002088612,0.9204911,0.00009622347,0.0004123639,0.07049826],"study_design_scores_gemma":[0.1021544,0.0635921,0.3655159,0.005005099,0.001416357,0.00003856179,0.004205846,0.001035512,0.4445686,0.001376189,0.008532302,0.002559047],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9163924,0.0006428055,0.04661841,0.02287602,0.0001855991,0.01313952,0.0001254828,0.00001742062,0.00000234507],"genre_scores_gemma":[0.9939522,0.001821337,0.002652666,0.0001113117,0.0006151797,0.0005710272,0.00009125823,0.00003222158,0.0001528195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4759225,"threshold_uncertainty_score":0.8303968,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990715538","doi":"10.1310/hct0901-43","title":"Systematic Review and Meta–Analysis of the Diagnostic Accuracy of Fibrosis Marker Panels in Patients with HIV/Hepatitis C Coinfection","year":2008,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"Canadian Liver Foundation","keywords":"Medicine; Cirrhosis; Receiver operating characteristic; Fibrosis; Internal medicine; Coinfection; Hepatitis C; Liver biopsy; Hepatitis C virus; Gastroenterology; Meta-analysis; Odds ratio; Biopsy; Human immunodeficiency virus (HIV); Pathology; Immunology; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.2869989979058875,"gpt":0.4954279116548407,"spread":0.2084289137489533,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.01070687,0.0004916656,0.02438928,0.0005383173,0.00004212488,0.00001495345,0.0003162689,0.0004390744,0.0005634126],"category_scores_gemma":[0.2176215,0.0002348314,0.004780133,0.002306207,0.0003380932,0.00007939733,0.0001738405,0.0007005768,0.00002860745],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009979455,"about_ca_system_score_gemma":0.0004682684,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002052006,"about_ca_topic_score_gemma":0.00005434447,"domain_scores_codex":[0.9759882,0.01413756,0.007861874,0.0006073528,0.001118692,0.0002862951],"domain_scores_gemma":[0.9135837,0.07896367,0.005196639,0.001526728,0.0005177897,0.0002114944],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.00006574933,0.0005412851,0.05742832,0.8309356,0.0951153,0.00001069581,0.00001443731,4.765772e-7,1.23745e-8,0.00000390076,0.0008006397,0.01508356],"study_design_scores_gemma":[0.001368324,0.0003300843,0.03243883,0.2277048,0.730561,0.000003874175,8.591832e-7,0.000004461132,1.979784e-7,0.000001862063,0.007373111,0.000212574],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002790247,0.9853466,0.0000132307,0.0001026248,0.0000600689,0.01301762,0.001077849,0.00001129702,0.00009169168],"genre_scores_gemma":[0.0005602327,0.997789,0.00006924428,0.000130429,0.00003541769,0.0009500619,0.000229528,0.0000508586,0.0001852328],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6354458,"threshold_uncertainty_score":0.9900947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1987974009","doi":"10.1310/hct0804-213","title":"Safety, Tolerability, and Efficacy of Darunavir (TMC114) with Low-Dose Ritonavir in Treatment-Experienced, Hepatitis B or C Co-infected Patients in POWER 1 and 3","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Darunavir; Ritonavir; Tolerability; Internal medicine; Regimen; Gastroenterology; Adverse effect; Hepatitis B; Hepatitis C; Alanine transaminase; Viral load; Virology; Human immunodeficiency virus (HIV); Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.09964593074584223,"gpt":0.4511300174849633,"spread":0.3514840867391211,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004174826,0.0002903146,0.002213311,0.0001899831,0.0000525079,0.00001413832,0.00006916893,0.0002353623,0.0001287053],"category_scores_gemma":[0.01389205,0.000194048,0.0001251228,0.0003784128,0.0006445723,0.0001066637,0.00008616244,0.0002521295,0.000008993467],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001501821,"about_ca_system_score_gemma":0.0001734696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002464976,"about_ca_topic_score_gemma":0.01594258,"domain_scores_codex":[0.9951171,0.0008202757,0.002711309,0.0006078762,0.0003480588,0.0003954277],"domain_scores_gemma":[0.9897467,0.009044151,0.0004372609,0.0003708863,0.000133369,0.0002675845],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01122981,0.002927312,0.952172,0.00004774953,0.00009310612,0.0001316277,0.0009704159,4.570322e-7,0.00006515359,0.00001322099,0.0000294352,0.03231972],"study_design_scores_gemma":[0.04303937,0.005613604,0.9493274,0.0004603865,0.00008023443,0.000004773538,0.0001080109,0.000009022347,0.0003625484,0.000019995,0.0007858204,0.0001888548],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965993,0.0001501662,0.00001105732,0.0001652478,0.0001349852,0.00208738,0.000112295,0.00002943886,0.000710167],"genre_scores_gemma":[0.9970525,0.002067268,0.0004742722,0.0001603692,0.00007548001,0.00004426821,0.00004066098,0.00002590663,0.00005927261],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03213087,"threshold_uncertainty_score":0.9944143,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050657418","doi":"10.1310/hct1101-39","title":"A Meta-Analysis of Six Placebo-Controlled Trials of Thiazolidinedione Therapy for HIV Lipoatrophy","year":2010,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; University of Toronto","funders":"National Center for Research Resources; U.S. Public Health Service; National Institutes of Health; Amgen; National Institute of Diabetes and Digestive and Kidney Diseases; Gilead Sciences; National Institute of Allergy and Infectious Diseases; Medical Research Council; ACT Government; Bristol-Myers Squibb; GlaxoSmithKline; National Health and Medical Research Council","keywords":"Pioglitazone; Rosiglitazone; Medicine; Placebo; Thiazolidinedione; Stavudine; Internal medicine; Lipoatrophy; Body mass index; Zidovudine; Urology; Endocrinology; Gastroenterology; Pharmacology; Diabetes mellitus; Human immunodeficiency virus (HIV); Antiretroviral therapy; Type 2 diabetes; Viral load; Insulin; Immunology; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.6418827890290362,"gpt":0.5873134464127776,"spread":0.05456934261625856,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.07327667,0.0008809281,0.08057743,0.001360891,0.0001065298,0.00002015649,0.0004722257,0.001925925,0.002206733],"category_scores_gemma":[0.06910448,0.0004488202,0.06134137,0.00138304,0.0002074574,0.00003880534,0.00004298166,0.001024691,0.00009603095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004845673,"about_ca_system_score_gemma":0.001494864,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001343676,"about_ca_topic_score_gemma":0.000003339547,"domain_scores_codex":[0.963353,0.01111105,0.02334133,0.001033701,0.0007216241,0.0004393429],"domain_scores_gemma":[0.8254839,0.1498561,0.02063809,0.002399984,0.001083433,0.0005385382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01392705,0.002635574,0.00001399275,0.003156701,0.7847621,0.000003568632,0.00003016319,0.000003570371,0.000003746365,0.0004824404,0.002818963,0.1921621],"study_design_scores_gemma":[0.02954615,0.0007762414,0.000003664168,0.0005556238,0.5758184,0.000001992829,0.0000032116,0.00003371031,0.000002780113,0.0001410858,0.3929451,0.0001720897],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003775727,0.9720044,0.0005441769,0.001216363,0.000529751,0.02064595,0.004579634,0.00004816142,0.0003938588],"genre_scores_gemma":[0.0001114853,0.9861189,0.00359209,0.0001602444,0.001101577,0.004926178,0.001998798,0.0001024228,0.001888378],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3901261,"threshold_uncertainty_score":0.9997963,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048157797","doi":"10.1310/hct1202-89","title":"Ethnicity and Gender Differences in Lipodystrophy of HIV-Positive Individuals Taking Antiretroviral Therapy in Ontario, Canada","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Kingston General Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital; Women's College Hospital; Ontario HIV Treatment Network; Canadians Living with HIV; Health Sciences Centre; University Health Network; University of Toronto","funders":"Division of Undergraduate Education","keywords":"Lipodystrophy; Medicine; Lipoatrophy; Multicenter AIDS Cohort Study; Internal medicine; Cross-sectional study; Logistic regression; Ethnic group; Cohort; Prospective cohort study; Univariate analysis; Multivariate analysis; Antiretroviral therapy; Human immunodeficiency virus (HIV); Immunology; Pathology; Viral load","retraction":null,"screen_n_in":null,"score":{"opus":0.3563934803590323,"gpt":0.4365928387934302,"spread":0.08019935843439796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002138769,0.0001508272,0.00115168,0.0001242739,0.00003889599,0.000005264489,0.00008554952,0.0001914662,0.0002875188],"category_scores_gemma":[0.001001801,0.0001107867,0.00009925863,0.0001729461,0.0001080346,0.00004230285,0.00003211289,0.0004709795,0.000004018933],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001382647,"about_ca_system_score_gemma":0.0009085512,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7609767,"about_ca_topic_score_gemma":0.553352,"domain_scores_codex":[0.9967022,0.0008772385,0.001641891,0.0003267936,0.000211277,0.0002406161],"domain_scores_gemma":[0.9972387,0.001717067,0.0005973404,0.000227938,0.00006034674,0.0001586124],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004277958,0.0005432985,0.9922464,0.00001488141,0.0001098196,0.00002440606,0.001097113,1.667863e-7,0.00002312987,0.0001522576,0.00009924993,0.005261444],"study_design_scores_gemma":[0.005806289,0.00081424,0.9924983,0.0001762323,0.00005961029,0.000002596487,0.00008627707,0.00001741843,0.00005068683,0.0003503587,0.00005139508,0.00008659453],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9968013,0.0003083357,0.00001862991,0.0001922462,0.0001161756,0.0007715288,0.00006286966,0.00000765447,0.001721245],"genre_scores_gemma":[0.9984087,0.0003050469,0.0008080669,0.0002587536,0.0000416915,0.0000289757,0.00002950751,0.000009624171,0.0001096163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2076247,"threshold_uncertainty_score":0.4547982,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035341996","doi":"10.1310/hct1002-76","title":"Long-Term Efficacy and Safety of Fosamprenavir plus Ritonavir Versus Lopinavir/Ritonavir in Combination with Abacavir/Lamivudine over 144 Weeks","year":2009,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Clair College","funders":"GlaxoSmithKline","keywords":"Medicine; Abacavir; Lopinavir/ritonavir; Lopinavir; Ritonavir; Interquartile range; Lamivudine; Adverse effect; Viral load; Internal medicine; Gastroenterology; Pharmacology; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Virus; Chronic hepatitis","retraction":null,"screen_n_in":null,"score":{"opus":0.128906631394485,"gpt":0.4384300801451987,"spread":0.3095234487507136,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003453566,0.0004287641,0.002139662,0.0002334677,0.00007793717,0.00002809003,0.0001575513,0.0003753993,0.000140534],"category_scores_gemma":[0.001994355,0.0003176734,0.0002942908,0.0004237501,0.0002677383,0.0001872839,0.00007051291,0.0005131379,0.0000568214],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001959311,"about_ca_system_score_gemma":0.0002954542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000172998,"about_ca_topic_score_gemma":0.00003346113,"domain_scores_codex":[0.9950539,0.0007247885,0.002460884,0.0007188764,0.0006126608,0.000428863],"domain_scores_gemma":[0.9943522,0.004045092,0.0006566879,0.0005065827,0.0001280426,0.0003114116],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.124667,0.01106427,0.4697827,0.0003363995,0.001563956,0.0008976953,0.0006825441,0.0000249801,0.0008174973,0.002648172,0.001776168,0.3857386],"study_design_scores_gemma":[0.1154311,0.003339131,0.8770053,0.001134638,0.0005795429,0.00001875357,0.00002979651,0.00009591082,0.0004062454,0.0001644825,0.001436849,0.0003581755],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899601,0.0006380404,0.0002365081,0.004061191,0.0004166689,0.00225859,0.00005523039,0.00007499415,0.002298698],"genre_scores_gemma":[0.9936683,0.001291945,0.001520114,0.0001822635,0.0003303498,0.00003913478,0.0004521847,0.00003622071,0.002479477],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4072226,"threshold_uncertainty_score":0.9999275,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1985542358","doi":"10.1179/1528433614z.0000000005","title":"<i>Tripterygium wilfordii</i>Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety","year":2015,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Natural Compounds in Disease Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"University of California, San Francisco","keywords":"Medicine; Tripterygium wilfordii; Discontinuation; Tripterygium; Cart; Immune system; Triptolide; Internal medicine; Combination therapy; T cell; Pharmacology; Immunology; Apoptosis","retraction":null,"screen_n_in":null,"score":{"opus":0.1926550705779997,"gpt":0.43823313118125,"spread":0.2455780606032503,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01187034,0.0005573266,0.002550098,0.0003838218,0.00009215416,0.0000673264,0.0002474778,0.0001559261,0.00003871002],"category_scores_gemma":[0.01636702,0.0003791327,0.0002371531,0.0006019753,0.0001135584,0.0002102223,0.000235251,0.0006174928,0.0001293151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004601846,"about_ca_system_score_gemma":0.0004222029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004539031,"about_ca_topic_score_gemma":0.00001473873,"domain_scores_codex":[0.9888718,0.006265972,0.00246544,0.0009658805,0.0008762135,0.0005546791],"domain_scores_gemma":[0.9890487,0.008039528,0.0005590635,0.0009795472,0.000434347,0.0009388385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2354048,0.01346818,0.7424525,0.00006361136,0.0007738493,0.0006258553,0.0001832249,0.000007196125,0.000934388,0.000004157415,0.002142366,0.003939919],"study_design_scores_gemma":[0.0690283,0.03287029,0.8947332,0.0004830826,0.0007876556,0.000008968479,0.0001017855,0.00001371576,0.0003291709,0.00001359487,0.001273439,0.0003567954],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902506,0.001233502,0.00001398155,0.0007144617,0.0006686408,0.006667674,0.00009762014,0.0001335818,0.0002198714],"genre_scores_gemma":[0.9972343,0.00002358258,0.0004988788,0.000445261,0.0002414256,0.0002451284,0.0001060773,0.00007798448,0.001127321],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1663764,"threshold_uncertainty_score":0.9998661,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2063088890","doi":"10.1310/hct1205-275","title":"Vitamin D Supplementation Does Not Increase Immunogenicity of Seasonal Influenza Vaccine in HIV-Infected Adults","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"HIV Legal Network; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Immunogenicity; Medicine; Seroconversion; Influenza vaccine; Vitamin; Human immunodeficiency virus (HIV); Population; Virology; Immunology; Physiology; Internal medicine; Antibody; Environmental health; Vaccination","retraction":null,"screen_n_in":null,"score":{"opus":0.1829241776040389,"gpt":0.4677940942539155,"spread":0.2848699166498766,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01221092,0.0002584499,0.001780129,0.00024623,0.00005475484,0.000009798458,0.000211395,0.0002300365,0.001870835],"category_scores_gemma":[0.05417006,0.0001696494,0.0004933884,0.0003905681,0.0001922479,0.0001384933,0.000251379,0.000494839,0.0001130469],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008189835,"about_ca_system_score_gemma":0.0002645557,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005570003,"about_ca_topic_score_gemma":0.0002126725,"domain_scores_codex":[0.9927984,0.002460822,0.003169283,0.0005001305,0.0006295562,0.0004418324],"domain_scores_gemma":[0.9911868,0.006763624,0.0007505675,0.0005460128,0.0004573062,0.0002957149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0208809,0.001955143,0.9582164,0.0002545461,0.000485098,0.0000693324,0.0005296093,4.226307e-7,0.008948114,0.00008795367,0.003383924,0.005188522],"study_design_scores_gemma":[0.03605139,0.001065972,0.9346437,0.000413005,0.0002571922,0.000004144411,0.0003080681,0.00007093616,0.02656677,0.0001278335,0.0003184516,0.0001724641],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964709,0.0001301261,0.00004563076,0.0006326344,0.0002242598,0.001559345,0.0004713367,0.00005090575,0.0004148292],"genre_scores_gemma":[0.9962701,0.0005181961,0.001876288,0.0003906041,0.0003759256,0.0001175805,0.0001662871,0.00002638861,0.0002585881],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04195914,"threshold_uncertainty_score":0.9990416,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163692526","doi":"10.1310/vqxj-41x6-gja2-h6ag","title":"Effect of Protease Inhibitor-Based Highly Active Antiretroviral Therapy on Survival in HIV-Associated Advanced Kaposi's Sarcoma Patients Treated with Chemotherapy","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"","keywords":"Medicine; Chemotherapy; Internal medicine; Vincristine; Regimen; Sarcoma; Gastroenterology; Indinavir; Chemotherapy regimen; Anthracycline; Protease inhibitor (pharmacology); Surgery; Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology; Cyclophosphamide; Pathology; Cancer","retraction":null,"screen_n_in":null,"score":{"opus":0.04470402048073586,"gpt":0.3771242272860323,"spread":0.3324202068052965,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005176415,0.0004678998,0.002544032,0.0001997688,0.00006405505,0.00001718743,0.000125352,0.0004584706,0.0000902813],"category_scores_gemma":[0.008744773,0.0003112251,0.0006129069,0.0006977908,0.0001875857,0.00009013244,0.000007826146,0.0005518983,0.00001433025],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002906898,"about_ca_system_score_gemma":0.0003573806,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008200048,"about_ca_topic_score_gemma":0.00001336869,"domain_scores_codex":[0.9912817,0.005181374,0.001679423,0.0006536482,0.00069403,0.0005098642],"domain_scores_gemma":[0.9940592,0.003865936,0.001196706,0.0004220192,0.0002196276,0.0002364968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1233301,0.004901773,0.8331935,0.00004986627,0.0004413697,0.00002330889,0.00006113292,0.00003873447,0.001950335,0.00001856089,0.0004129455,0.0355783],"study_design_scores_gemma":[0.391051,0.0883302,0.3880407,0.0009943591,0.0003098475,2.810466e-7,0.00004841654,0.00006259563,0.1298983,0.00003930879,0.0005971252,0.0006278988],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942033,0.00007815765,0.000007874055,0.0002921729,0.000220124,0.004013898,0.0001486424,0.00008579076,0.000950026],"genre_scores_gemma":[0.998538,0.0001350643,0.00005893156,0.0005841131,0.0000794075,0.0001742443,0.0002121273,0.00007716719,0.0001409063],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4451528,"threshold_uncertainty_score":0.999934,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2089422405","doi":"10.1310/0xh7-f2v2-1k0r-nu2w","title":"Prognostic Staging of Extensively Pretreated Patients with Advanced HIV-1 Disease","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital; St. Paul's Hospital","funders":"","keywords":"Medicine; Enfuvirtide; Regimen; Internal medicine; Confidence interval; Odds ratio; Viral load; Randomization; Logistic regression; Clinical trial; Human immunodeficiency virus (HIV); Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.08973515316492171,"gpt":0.4063030425292003,"spread":0.3165678893642786,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001224018,0.0002388399,0.001202384,0.00009861279,0.00004689622,0.00001087484,0.00007692142,0.0000786335,0.0002584152],"category_scores_gemma":[0.008850142,0.0001499579,0.0002652302,0.0002002275,0.0001202357,0.00009869682,0.0000367613,0.000152244,0.0002024435],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005128422,"about_ca_system_score_gemma":0.000259406,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":5.275696e-7,"about_ca_topic_score_gemma":6.547237e-7,"domain_scores_codex":[0.9968694,0.0004131379,0.001550582,0.0004386973,0.0004440838,0.0002841364],"domain_scores_gemma":[0.9961369,0.002147895,0.0005457499,0.0003577649,0.0003675964,0.0004440777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.005553167,0.001984095,0.9554344,0.00006121382,0.0003973451,0.00004680595,0.00008622569,0.00001454512,0.0000132756,0.00002340041,0.002763879,0.03362166],"study_design_scores_gemma":[0.02595364,0.0005976517,0.9629265,0.0007716229,0.001224855,7.688898e-7,0.00003248346,0.0001146635,0.0002539436,0.00002853995,0.007872788,0.0002225112],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9937641,0.0001878384,0.000169883,0.002790678,0.0001041855,0.002154081,0.0001300281,0.0000888689,0.0006103473],"genre_scores_gemma":[0.9852126,0.0001047867,0.008016078,0.0002618681,0.0001951921,0.00007832785,0.0003540185,0.00003522234,0.00574197],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03339915,"threshold_uncertainty_score":0.9994987,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2078593189","doi":"10.1310/2xvk-pbgl-735n-wh72","title":"Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations","year":2006,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Montreal General Hospital; Maple Leaf Medical Clinic","funders":"","keywords":"Enfuvirtide; Ritonavir; Concomitant; Medicine; Protease inhibitor (pharmacology); Lopinavir; Regimen; Viral load; Pharmacology; Internal medicine; Protease; Virology; Human immunodeficiency virus (HIV); Immunology; Gp41; Antiretroviral therapy; Biology; Enzyme","retraction":null,"screen_n_in":null,"score":{"opus":0.4705395474442008,"gpt":0.5174414029777028,"spread":0.04690185553350196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003663682,0.0008033213,0.006531526,0.0004482394,0.00009052298,0.00006874881,0.0002268972,0.0005778226,0.0001669927],"category_scores_gemma":[0.01141977,0.0004957747,0.0003277751,0.0006985502,0.000403882,0.0002111168,0.0001917518,0.0005436824,0.00002949391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003408827,"about_ca_system_score_gemma":0.002489409,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006074248,"about_ca_topic_score_gemma":0.000178236,"domain_scores_codex":[0.9879429,0.005064563,0.004814952,0.001337086,0.0004057107,0.0004348307],"domain_scores_gemma":[0.9836466,0.01174692,0.002507887,0.001390499,0.0002273836,0.0004807122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001832527,0.004362983,0.005377381,0.0008507096,0.001977978,0.0003339973,0.0002744315,1.759591e-7,0.0000019392,0.00001158681,0.00683333,0.978143],"study_design_scores_gemma":[0.01716867,0.001350765,0.0003827033,0.009739674,0.004981916,0.00007881435,0.0001733854,0.0000168196,0.00005377585,0.000006723104,0.9655459,0.0005008613],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0574807,0.856878,0.00003805281,0.004828272,0.0008200047,0.0468287,0.03226652,0.0003412083,0.0005185052],"genre_scores_gemma":[0.0001340265,0.9674606,0.008697753,0.00005043325,0.0002889322,0.0009819973,0.02104529,0.00009313971,0.00124787],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9776421,"threshold_uncertainty_score":0.9997494,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2058157173","doi":"10.1310/a9b9-rqd7-u8ka-503u","title":"Comparison of Prognostic Importance of Latest CD4+ Cell Count and HIV RNA Levels in Patients with Advanced HIV Infection on Highly Active Antiretroviral Therapy","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Viral load; Medicine; Hazard ratio; Regimen; Antiretroviral therapy; Internal medicine; Immunology; Human immunodeficiency virus (HIV); Virology; Gastroenterology; Confidence interval","retraction":null,"screen_n_in":null,"score":{"opus":0.1052719748358848,"gpt":0.4184110854366108,"spread":0.313139110600726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001193548,0.0001859137,0.001078,0.0001021994,0.00004711921,0.000005836406,0.00008690971,0.0002148841,0.0001009556],"category_scores_gemma":[0.001045663,0.0001249387,0.0001134239,0.000128738,0.0002758005,0.00009682934,0.00002683769,0.0003331842,0.00008281946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004450148,"about_ca_system_score_gemma":0.00009058694,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001597355,"about_ca_topic_score_gemma":0.00002783504,"domain_scores_codex":[0.9970481,0.001003187,0.001237857,0.0003401984,0.00009839582,0.0002722768],"domain_scores_gemma":[0.9960547,0.002806343,0.0007530656,0.0002202834,0.0001217252,0.00004385276],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007569657,0.003368398,0.9608217,0.0000181366,0.0001692414,0.000001404851,0.00011853,0.00002656358,0.003981707,0.00002122332,0.0002817779,0.0236217],"study_design_scores_gemma":[0.02146059,0.007118792,0.9333156,0.00009570983,0.00003859939,2.513992e-7,0.00002331125,0.00000554038,0.03693338,0.00001316416,0.0008789873,0.0001161313],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975467,0.000456295,0.00001319209,0.0001123716,0.0001033494,0.001121153,0.000431795,0.0000154685,0.0001996672],"genre_scores_gemma":[0.9991434,0.0002767793,0.0001175352,0.00002821079,0.0000284537,0.00003574162,0.000228831,0.00001303222,0.0001280394],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03295167,"threshold_uncertainty_score":0.5094854,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1991408322","doi":"10.1310/hct0806-400","title":"Effectiveness and Tolerability of Oral Administration of Low-Dose Salmon Oil to HIV Patients with HAART-Associated Dyslipidemia","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Abbott (Canada); Université Laval; Centre hospitalier de l'Université Laval; Maple Leaf Medical Clinic","funders":"Abbott Canada; Abbott Laboratories","keywords":"Medicine; Dyslipidemia; Tolerability; Fish oil; Adverse effect; Concomitant; Internal medicine; Triglyceride; Gastroenterology; Cholesterol; Fish <Actinopterygii>; Fishery; Disease","retraction":null,"screen_n_in":null,"score":{"opus":0.09556612374720039,"gpt":0.4636352470363737,"spread":0.3680691232891733,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00887163,0.000151599,0.001351862,0.00008216318,0.00005319833,0.000004547197,0.00005408876,0.0002407334,0.00003124802],"category_scores_gemma":[0.009462069,0.0001086395,0.0001451576,0.0002856171,0.0001185623,0.00004451508,0.00002392137,0.0001907639,0.00001612943],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000817883,"about_ca_system_score_gemma":0.0002060261,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000267685,"about_ca_topic_score_gemma":0.00002526409,"domain_scores_codex":[0.9960378,0.0009939045,0.002121163,0.0003576731,0.0002795297,0.0002098924],"domain_scores_gemma":[0.9924266,0.005605151,0.0008056578,0.0003613296,0.0004704903,0.0003308006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01161212,0.003160887,0.9561957,0.000271509,0.0001929541,0.00000351744,0.00005502271,0.000003490929,0.0001555264,0.00005137748,0.0001420202,0.0281559],"study_design_scores_gemma":[0.01270365,0.003094261,0.982274,0.0007131814,0.0002594605,6.858878e-7,0.0000115176,0.00002465867,0.0006420239,0.00006454084,0.000127805,0.00008421973],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9976083,0.00002962546,0.000301764,0.0003815429,0.0001120297,0.001090541,0.0001132526,0.00002438042,0.0003385446],"genre_scores_gemma":[0.9985004,0.00001401107,0.00111495,0.00007809058,0.00003787611,0.00003099226,0.0001336166,0.00001427436,0.00007580448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02807168,"threshold_uncertainty_score":0.9988816,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2085481779","doi":"10.1310/hct1105-260","title":"A Pilot Study of Abacavir/Lamivudine and Raltegravir in Antiretroviral-Naïve HIV-1–Infected Patients: 48-Week Results of the SHIELD Trial","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"University of Saskatchewan","keywords":"Raltegravir; Abacavir; Medicine; Lamivudine; Adverse effect; Viral load; Internal medicine; Discontinuation; Gastroenterology; Human immunodeficiency virus (HIV); Virology; Chronic hepatitis; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.152403599521089,"gpt":0.4151683571378847,"spread":0.2627647576167957,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006874548,0.0002821464,0.001975944,0.0001920177,0.00005270512,0.00001443926,0.0001980076,0.0001668719,0.00005821578],"category_scores_gemma":[0.02826018,0.0001631475,0.0002998484,0.0004859421,0.0002534496,0.00007379158,0.0001489533,0.0006690662,0.00002294642],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002342196,"about_ca_system_score_gemma":0.0001984734,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001034508,"about_ca_topic_score_gemma":0.000254049,"domain_scores_codex":[0.9934268,0.001527943,0.003722098,0.0005125159,0.0005380371,0.0002725766],"domain_scores_gemma":[0.992402,0.005358677,0.001232084,0.0006762806,0.0001689898,0.0001619593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1447896,0.02460492,0.8188484,0.00004475143,0.0004031026,0.00001790854,0.0006508117,3.845697e-7,0.0009118622,0.00004860762,0.00326709,0.00641259],"study_design_scores_gemma":[0.3551731,0.01529236,0.6270727,0.0002170711,0.0005567938,0.000001204676,0.000192935,0.00001544522,0.0005848349,0.00008649987,0.0006260982,0.0001809706],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928184,0.00002264645,0.000001712865,0.0009496685,0.00104315,0.004095298,0.0001235504,0.00002524967,0.0009203634],"genre_scores_gemma":[0.9968096,0.00006479825,0.0002416484,0.0000590718,0.0003263652,0.0000588496,0.00006979179,0.00002402137,0.00234583],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2103835,"threshold_uncertainty_score":0.9799252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023680960","doi":"10.1310/hct1106-340","title":"Effect of Gender and Calendar Year on Time to and Duration of Virologic Suppression Among Antiretroviral-Naïve HIV-Infected Individuals Initiating Combination Antiretroviral Therapy","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; Maple Leaf Medical Clinic; Ontario HIV Treatment Network; St. Michael's Hospital; Public Health Ontario; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Health Canada; Ontario HIV Treatment Network","keywords":"Medicine; Cart; Interquartile range; Hazard ratio; Regimen; Proportional hazards model; Viral load; Antiretroviral therapy; Cohort; Internal medicine; Human immunodeficiency virus (HIV); Cohort study; Confidence interval; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.09042930505775788,"gpt":0.447746397133398,"spread":0.3573170920756401,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01136324,0.0001734877,0.001040445,0.0002748836,0.00007491502,0.00002278006,0.00008597079,0.0003080492,0.0005003257],"category_scores_gemma":[0.02991866,0.0001196723,0.0002667432,0.0001976794,0.0002893735,0.0001475762,0.00007563962,0.0005204795,0.00005531188],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00000925873,"about_ca_system_score_gemma":0.00004232735,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001124768,"about_ca_topic_score_gemma":6.838584e-7,"domain_scores_codex":[0.9945293,0.003037489,0.001467233,0.000340424,0.0004088529,0.0002167189],"domain_scores_gemma":[0.9933864,0.005371158,0.0005913952,0.0002670565,0.0001547029,0.0002293202],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00228346,0.0005257609,0.6768793,0.0001522548,0.0001479441,0.000004819351,0.0001217228,3.357101e-7,0.256287,0.0001016214,0.005411089,0.0580846],"study_design_scores_gemma":[0.01326805,0.05059472,0.8453453,0.0003784859,0.000159886,0.000004060947,0.00002637541,0.001210632,0.08850285,0.0001142495,0.0002291462,0.0001662071],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971664,0.0000391067,0.00009778857,0.0001666888,0.00008812892,0.001326499,0.0002786872,0.00003179561,0.0008049263],"genre_scores_gemma":[0.9987797,0.0001145176,0.0002289017,0.00005269242,0.0001597408,0.00002303263,0.0001355106,0.0000187246,0.0004871799],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.168466,"threshold_uncertainty_score":0.9782528,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071621051","doi":"10.1310/hag3-8ya5-udqc-36nx","title":"Virologic and Immunologic Response to a Boosted Double-Protease Inhibitor-Based Therapy in Highly Pretreated HIV-1-Infected Patients","year":2005,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; McGill University Health Centre","funders":"Canadian Institutes of Health Research; Abbott Canada; Abbott Laboratories","keywords":"Saquinavir; Medicine; Lopinavir; Regimen; Protease inhibitor (pharmacology); Internal medicine; Ritonavir; Viral load; Lamivudine; Gastroenterology; Immunology; Odds ratio; Reverse-transcriptase inhibitor; Nelfinavir; Drug resistance; Pharmacology; Virology; Virus; Antiretroviral therapy; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1259546533319276,"gpt":0.4069000041686832,"spread":0.2809453508367556,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006143239,0.0004120853,0.001576063,0.0004274724,0.00008638183,0.00004173346,0.0001248339,0.0004485641,0.0003128786],"category_scores_gemma":[0.008033012,0.0002774453,0.0002880787,0.0005751186,0.000132807,0.00008405837,0.00007197527,0.0003916694,0.0005326293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00019067,"about_ca_system_score_gemma":0.0002764937,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001006911,"about_ca_topic_score_gemma":0.000007338472,"domain_scores_codex":[0.9933051,0.002956181,0.002151899,0.0007571513,0.000346837,0.0004828473],"domain_scores_gemma":[0.9944987,0.004041793,0.0003968761,0.0005015405,0.0001624076,0.0003987001],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2268108,0.005721848,0.721313,0.00002091241,0.0003612838,0.000188711,0.0002787813,0.00001645974,0.005094424,0.000008796261,0.005596448,0.03458856],"study_design_scores_gemma":[0.1412928,0.005586782,0.8178546,0.0003092711,0.0001860229,0.000004084556,0.00002409316,0.0001324938,0.009393724,0.00002315534,0.02471732,0.0004756509],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.980963,0.000255563,0.00001342057,0.01390066,0.0001590207,0.004264613,0.00005042668,0.0002042868,0.00018899],"genre_scores_gemma":[0.9932051,0.0001623308,0.001670003,0.001603598,0.0001837668,0.000388158,0.0001837233,0.00003632733,0.00256699],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09654162,"threshold_uncertainty_score":0.9999678,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988473048","doi":"10.1310/feed-6t8u-0bug-6hqh","title":"Randomized Trials Stopped Early for Harm in HIV/AIDS: A Systematic Survey","year":2006,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University; University of British Columbia; AIDS Vancouver; University of Ottawa","funders":"International AIDS Society","keywords":"Medicine; Data monitoring committee; Interim; Harm; Randomized controlled trial; Adverse effect; Psychological intervention; Clinical trial; Population; Family medicine; Environmental health; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.9477098910306675,"gpt":0.7483044210610479,"spread":0.1994054699696196,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"category_scores_codex":[0.8455175,0.001419088,0.09732977,0.001143793,0.0001225501,0.0003070099,0.001614299,0.006871051,0.0003826326],"category_scores_gemma":[0.9829137,0.0008455617,0.02313246,0.001316631,0.001107434,0.00009729205,0.0004077707,0.008336134,0.001187852],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004061115,"about_ca_system_score_gemma":0.006001247,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001775609,"about_ca_topic_score_gemma":0.0001406058,"domain_scores_codex":[0.5090577,0.3967606,0.08329055,0.003960177,0.004725527,0.002205448],"domain_scores_gemma":[0.02419385,0.9560202,0.01385551,0.003124111,0.001786911,0.001019457],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1852221,0.002063673,0.0001039258,0.7307497,0.006274474,0.0001290393,0.00003545124,4.349941e-7,1.583477e-7,0.004599247,0.01594067,0.05488108],"study_design_scores_gemma":[0.4664835,0.001006302,0.00001660218,0.37331,0.02156848,0.00001146394,0.00001343884,0.00003080711,3.333396e-7,0.00888924,0.1277983,0.0008715488],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000193646,0.9230149,0.001991103,0.0005671745,0.002712779,0.06884875,0.001941847,0.0001422777,0.0007617442],"genre_scores_gemma":[0.0000172903,0.9547511,0.003566728,0.0002973824,0.00428706,0.009917538,0.001432502,0.0003128209,0.02541761],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5592595,"threshold_uncertainty_score":0.9998559,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2003655730","doi":"10.1310/b6t0-n98j-1j3m-eqpk","title":"Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens","year":2002,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"AIDS Vancouver; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Adverse effect; Abacavir; Mycophenolate; Internal medicine; Salvage therapy; Human immunodeficiency virus (HIV); Pharmacology; Viral load; Immunology; Antiretroviral therapy; Chemotherapy; Transplantation","retraction":null,"screen_n_in":null,"score":{"opus":0.2900278795689513,"gpt":0.4613258626269102,"spread":0.1712979830579589,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004355104,0.0002605273,0.001673177,0.00006714511,0.0001413261,0.00001759194,0.00009066304,0.0001699646,0.0008807281],"category_scores_gemma":[0.00348444,0.0001395078,0.0006446282,0.0001970869,0.0002831238,0.00009555439,0.00004984702,0.0001694693,0.0001615675],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007460237,"about_ca_system_score_gemma":0.0001273807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003070228,"about_ca_topic_score_gemma":0.000009701094,"domain_scores_codex":[0.9949781,0.001453886,0.002612948,0.0003700136,0.000321166,0.0002638523],"domain_scores_gemma":[0.9932697,0.005009998,0.0007135792,0.0006901145,0.0001323048,0.0001843339],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.018611,0.02434929,0.1990332,0.0006953318,0.01868129,0.02410148,0.02125119,0.0001178096,0.004339277,0.004576293,0.1217943,0.5624496],"study_design_scores_gemma":[0.1015784,0.006198164,0.008705049,0.002596708,0.008143618,0.006424027,0.0050461,0.001071168,0.04802552,0.0009927561,0.809898,0.001320505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9751467,0.001410094,0.00003684948,0.01052816,0.0005851053,0.00185756,0.00009809477,0.00006531607,0.01027219],"genre_scores_gemma":[0.9461008,0.004948211,0.004584917,0.0001436828,0.0004968388,0.00006431253,0.00004090416,0.00003796555,0.04358233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6881037,"threshold_uncertainty_score":0.9643355,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2144136328","doi":"10.1310/hct1105-312","title":"A Randomized, Placebo-Controlled Trial of Abacavir Intensification in HIV-1–Infected Adults With Virologic Suppression on a Protease Inhibitor–Containing Regimen","year":2010,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; College of Medicine, University of Cincinnati; University at Buffalo; University of California, San Diego; BioCryst; Deutsches Krebsforschungszentrum; International AIDS Society; University of Cincinnati; Johns Hopkins University; ACT Government; Georgia Clinical and Translational Science Alliance; Tulane University; University of Minnesota; University of Rochester; University of Miami; Northwestern University; York University; Bristol-Myers Squibb; University of Pennsylvania; Gilead Sciences; Vanderbilt University; Emory University; University of Nebraska Medical Center; National Institutes of Health; Ohio State University; University of Southern California; GlaxoSmithKline","keywords":"Medicine; Abacavir; Zidovudine; Regimen; Internal medicine; Lamivudine; Clinical endpoint; Placebo; Viral load; Indinavir; Population; Efavirenz; Discontinuation; Adverse effect; Gastroenterology; Randomized controlled trial; Immunology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Viral disease; Virus; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.06691439298854879,"gpt":0.3846769090118663,"spread":0.3177625160233175,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01766849,0.000377157,0.004103484,0.000330632,0.00005658979,0.00002091651,0.0001239122,0.0004788631,0.000130781],"category_scores_gemma":[0.05392823,0.0002079982,0.0007097296,0.0002553069,0.0002652789,0.00008248122,0.00004288872,0.000863389,0.00008936341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000496254,"about_ca_system_score_gemma":0.0003685393,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001360255,"about_ca_topic_score_gemma":0.00001663168,"domain_scores_codex":[0.9912134,0.003747973,0.003521409,0.0006738525,0.0005082809,0.0003351199],"domain_scores_gemma":[0.9833497,0.01387857,0.00167161,0.0005840738,0.0002511042,0.0002648828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9889856,0.002700801,0.002488853,0.00003432045,0.0004155121,0.00007108256,0.0004188937,0.000002741076,0.001174464,0.0001473526,0.0004591481,0.003101215],"study_design_scores_gemma":[0.9913904,0.002936139,0.0009821963,0.0009122489,0.0006707912,0.000007899755,0.0001267402,0.000563856,0.001826799,0.0001063084,0.0002650006,0.0002115904],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735858,0.00002221143,0.00007690061,0.003842637,0.0005273025,0.02020985,0.00001159702,0.00008788593,0.001635779],"genre_scores_gemma":[0.9929525,0.00005492997,0.001826976,0.0001501664,0.000610562,0.00276321,0.0001434211,0.00003368322,0.001464609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03625973,"threshold_uncertainty_score":0.9540409,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1970660282","doi":"10.1310/9m23-qn0x-w6n8-80jd","title":"Long-Term Follow-up of a Cohort of HIV-Infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"Ontario HIV Treatment Network","keywords":"Cytomegalovirus retinitis; Medicine; Discontinuation; Retinitis; Maintenance therapy; Cohort; Internal medicine; Cytomegalovirus; Prospective cohort study; Immunology; Human cytomegalovirus; Viral disease; Human immunodeficiency virus (HIV); Herpesviridae; Chemotherapy; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.1184162698467506,"gpt":0.4288857596610925,"spread":0.310469489814342,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00744173,0.0003346065,0.00311737,0.0002359124,0.00007392991,0.00003325108,0.0002980842,0.0004042906,0.0005586033],"category_scores_gemma":[0.01202283,0.0002467284,0.001542472,0.000410881,0.0004767981,0.000103955,0.00008730628,0.0003937427,0.00005064399],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006109763,"about_ca_system_score_gemma":0.0003112476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001777386,"about_ca_topic_score_gemma":0.00007164212,"domain_scores_codex":[0.9930568,0.0009460455,0.003965306,0.0006574506,0.000763735,0.0006106004],"domain_scores_gemma":[0.9907107,0.005783638,0.001440082,0.0007792753,0.001022461,0.0002638141],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01987473,0.001716097,0.9323669,0.0001926845,0.0005732916,0.00001530217,0.0000364125,5.918754e-7,0.002616095,0.0002197715,0.02370082,0.01868731],"study_design_scores_gemma":[0.04780597,0.002048184,0.9295969,0.0005272324,0.0003124046,0.000002266174,0.000006697499,0.0000374321,0.007708468,0.0002575614,0.01144145,0.0002554577],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904495,0.0003132322,0.000590465,0.0003786035,0.0004789268,0.004411956,0.001251163,0.00004926436,0.002076833],"genre_scores_gemma":[0.9911575,0.001200816,0.0003905583,0.0001524964,0.0008505351,0.0002019265,0.0005019278,0.00007632889,0.005467892],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02793125,"threshold_uncertainty_score":0.9999985,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034769242","doi":"10.1310/3hhb-59up-93mm-aaxy","title":"HIV Lipodystrophy: A Review","year":2000,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Lipodystrophy; Medicine; Stavudine; Diabetes mellitus; Hyperlipidemia; Metabolic syndrome; Antiretroviral therapy; Bioinformatics; Human immunodeficiency virus (HIV); Intensive care medicine; Immunology; Endocrinology; Viral load; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.5069420519687867,"gpt":0.6030165185156607,"spread":0.09607446654687402,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.007558459,0.0006567799,0.01252855,0.0001830498,0.0001280843,0.00002277467,0.0003213651,0.001024567,0.005214755],"category_scores_gemma":[0.007555667,0.0004170407,0.004358347,0.0005962602,0.0001146374,0.00003352843,0.00005786829,0.001473205,0.02912368],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001520491,"about_ca_system_score_gemma":0.001523843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004503844,"about_ca_topic_score_gemma":2.042494e-7,"domain_scores_codex":[0.9861121,0.004060654,0.007916921,0.00100732,0.000408455,0.0004945599],"domain_scores_gemma":[0.9880304,0.006974146,0.002178209,0.001844195,0.0001383001,0.0008346948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004177601,0.0004729929,0.000007576881,0.03481414,0.000618295,0.00007237015,0.000001125734,9.092781e-9,1.23999e-9,0.00005282767,0.1572914,0.8066275],"study_design_scores_gemma":[0.00161678,0.0002794458,0.00000718591,0.195708,0.012222,0.0001240076,2.728567e-7,8.972854e-7,3.483405e-9,0.00003525848,0.7897795,0.000226621],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[2.068649e-7,0.9771903,0.00001544018,0.002123689,0.0004282148,0.006656687,0.000441561,0.000153096,0.01299086],"genre_scores_gemma":[9.2411e-8,0.9750205,0.001048237,0.001846636,0.00192129,0.0008730461,0.001852295,0.0001070611,0.01733079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8064009,"threshold_uncertainty_score":0.9998282,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1988113084","doi":"10.1310/f45l-fdkk-y48n-n2bt","title":"Comparative CD4 T-Cell Responses of Reverse Transcriptase Inhibitor Therapy With or Without Nelfinavir Matched for Viral Exposure","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Nelfinavir; Medicine; Viral load; Quartile; Protease inhibitor (pharmacology); Internal medicine; Amprenavir; Indinavir; Area under the curve; Gastroenterology; Immunology; Pharmacology; Confidence interval; Virus; Protease; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.336951842305224,"gpt":0.4781353444316747,"spread":0.1411835021264507,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00427514,0.0003294006,0.002422378,0.0001383939,0.00007646216,0.00001724491,0.0001122915,0.0002137929,0.0003372769],"category_scores_gemma":[0.001447701,0.0001832702,0.0005186975,0.0002691421,0.0002239693,0.00008678126,0.00001201815,0.000204681,0.00005056331],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003834206,"about_ca_system_score_gemma":0.0006483224,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006040227,"about_ca_topic_score_gemma":0.000009081162,"domain_scores_codex":[0.9958585,0.001086856,0.001892352,0.0004718328,0.0003544405,0.000336025],"domain_scores_gemma":[0.9946668,0.003811317,0.0005715768,0.0004014549,0.0002118639,0.0003370296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.6643287,0.009367252,0.1901525,0.0002239491,0.002170133,0.0004001283,0.005136255,0.000002811397,0.02255025,0.00009161055,0.09745477,0.008121604],"study_design_scores_gemma":[0.2842488,0.02866218,0.01172553,0.001270939,0.002678891,0.00009354138,0.004151215,0.00009196639,0.1344985,0.0002626686,0.5311776,0.001138154],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9905329,0.0003900255,0.0006452006,0.00376335,0.0002579899,0.003577258,0.0001678541,0.00006864775,0.0005967328],"genre_scores_gemma":[0.9131902,0.0008089888,0.01910479,0.0007779747,0.0005103191,0.0003107831,0.0001388795,0.00004717306,0.06511086],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4337228,"threshold_uncertainty_score":0.747354,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2013976388","doi":"10.1310/p52n-kxjh-1945-ux7x","title":"The Cost-Effectiveness of Triple Nucleoside Analogue Therapy Antiretroviral Regimens in the Treatment of HIV in the United Kingdom","year":2000,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Life expectancy; Nucleoside analogue; Quality-adjusted life year; Cost effectiveness; Clinical trial; Quality of life (healthcare); Observational study; Population; Antiretroviral therapy; Human immunodeficiency virus (HIV); Intensive care medicine; Viral load; Internal medicine; Nucleoside; Family medicine; Environmental health; Risk analysis (engineering)","retraction":null,"screen_n_in":null,"score":{"opus":0.2806454061765764,"gpt":0.465997805989622,"spread":0.1853523998130456,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01453437,0.0002517489,0.001356168,0.0001577928,0.00009759766,0.0000224953,0.0003097653,0.0001566592,0.00009215896],"category_scores_gemma":[0.001450701,0.00009917899,0.0005420923,0.0008639056,0.0003191852,0.00003559084,0.00001064553,0.0002287592,0.00002899077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008777246,"about_ca_system_score_gemma":0.0001600545,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002491285,"about_ca_topic_score_gemma":0.00006992878,"domain_scores_codex":[0.9892146,0.007896333,0.001840639,0.0003148668,0.0004233112,0.0003102624],"domain_scores_gemma":[0.9788746,0.01989248,0.0004162623,0.0006974389,0.00006244408,0.00005675311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02620843,0.01242099,0.8252571,0.00005261208,0.00130147,0.0002495213,0.005229325,0.00004462542,0.0003523895,0.002336012,0.003846216,0.1227013],"study_design_scores_gemma":[0.05326574,0.004381152,0.7888859,0.0003797965,0.0004217706,0.0000128862,0.0008935692,0.0001282699,0.001964494,0.0005186717,0.1489333,0.000214486],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9907299,0.0004421076,0.000006662573,0.003976643,0.0001336353,0.003892389,0.00004424439,0.00001330462,0.0007611214],"genre_scores_gemma":[0.9936045,0.00461862,0.00006796367,0.0002470986,0.0001422571,0.0002813815,0.0001343154,0.0000180786,0.0008857493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1450871,"threshold_uncertainty_score":0.5037351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2136451994","doi":"10.1310/7lyw-gqff-wprq-k3qw","title":"Clinical Impact of Double Protease Inhibitor Boosting with Lopinavir/Ritonavir and Amprenavir as Part of Salvage Antiretroviral Therapy","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; Women's College Hospital; Health Sciences Centre; Canadians Living with HIV; Sunnybrook Health Science Centre; University of Waterloo; University Health Network; University of Toronto; Montreal General Hospital; McGill University","funders":"Abbott Laboratories","keywords":"Lopinavir; Medicine; Amprenavir; Ritonavir; Regimen; Salvage therapy; Internal medicine; Hazard ratio; Atazanavir; Lopinavir/ritonavir; Protease inhibitor (pharmacology); Viral load; Human immunodeficiency virus (HIV); Antiretroviral therapy; Confidence interval; Immunology; Protease; Chemotherapy; HIV-1 protease","retraction":null,"screen_n_in":null,"score":{"opus":0.2044627533897381,"gpt":0.483843551421669,"spread":0.2793807980319309,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008796408,0.0003735818,0.002549748,0.00010913,0.00006773002,0.00002268984,0.0001051625,0.0003250883,0.0002289877],"category_scores_gemma":[0.005136954,0.0002236263,0.0008328555,0.0002769751,0.0005172547,0.0001236979,0.00004461648,0.0004461024,0.00003443471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003950076,"about_ca_system_score_gemma":0.0008566378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004134416,"about_ca_topic_score_gemma":0.000001756884,"domain_scores_codex":[0.9936108,0.001531523,0.003361173,0.0006158508,0.0004955853,0.0003850771],"domain_scores_gemma":[0.9942107,0.003316389,0.001276432,0.0005359853,0.0002039129,0.0004565679],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01217024,0.002193864,0.957266,0.00008997108,0.001057897,0.00009241288,0.0001076939,7.940374e-7,0.0006860379,0.0001864591,0.001450361,0.02469832],"study_design_scores_gemma":[0.249449,0.05073906,0.59939,0.005162877,0.002564447,0.0002047075,0.0003989576,0.00004361686,0.05218899,0.0008639235,0.03730661,0.001687812],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946333,0.0006919254,0.00003169092,0.0003099888,0.0002354994,0.002312044,0.00004504242,0.00004599245,0.001694582],"genre_scores_gemma":[0.992366,0.001000313,0.003631146,0.00009859479,0.0004799177,0.00006334602,0.00004965389,0.00004665857,0.002264364],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.357876,"threshold_uncertainty_score":0.9119216,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2048476931","doi":"10.1310/cwd3-dr4k-7ee0-7abl","title":"The Efficacy of Calcium Carbonate in the Treatment of Protease Inhibitor-Induced Persistent Diarrhea in HIV-Infected Patients","year":2004,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Canadian Pharmacists Association; Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Diarrhea; Internal medicine; Visual analogue scale; Calcium carbonate; Calcium; Nelfinavir; Prospective cohort study; Gastroenterology; Human immunodeficiency virus (HIV); Surgery; Immunology; Antiretroviral therapy; Viral load","retraction":null,"screen_n_in":null,"score":{"opus":0.1797126751218041,"gpt":0.4497504274225439,"spread":0.2700377523007398,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002755875,0.0001888224,0.0010218,0.0001179263,0.00008030543,0.00000734426,0.0001335091,0.0001915912,0.000009790432],"category_scores_gemma":[0.004216193,0.00009412214,0.000530588,0.0004317479,0.0001270662,0.00002207956,0.00001836741,0.0002503689,0.00002827235],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002590919,"about_ca_system_score_gemma":0.0003715803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004172958,"about_ca_topic_score_gemma":0.00005549621,"domain_scores_codex":[0.9951181,0.001472919,0.002475055,0.0003116013,0.0003358187,0.0002864941],"domain_scores_gemma":[0.9937483,0.004661893,0.0006473747,0.000641962,0.0001497636,0.0001506997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007088962,0.04258671,0.912806,0.0001192097,0.0005814629,0.00005073749,0.003525871,0.0001455681,0.0003067563,0.000539182,0.0001807114,0.03206882],"study_design_scores_gemma":[0.05450179,0.005307593,0.9371111,0.0004793269,0.0003809776,0.000002035794,0.0001455721,0.00008186461,0.0006391431,0.0001408779,0.001095481,0.0001141692],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9908557,0.0002937177,0.000002594032,0.003395955,0.0001808715,0.004784944,0.00004841592,0.00001312954,0.0004246701],"genre_scores_gemma":[0.9989337,0.0003366877,0.00007205884,0.00007347656,0.0001106541,0.0003420026,0.00006715286,0.0000150036,0.00004926506],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04741283,"threshold_uncertainty_score":0.5047481,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W118439278","doi":"10.1310/m0cv-r6bx-a9dp-jjv0","title":"Circulating Levels of IL-7 but not IL-15, IGF-1, and TGF-β Are Elevated During Primary HIV-1 Infection","year":2004,"lang":"en","type":"letter","venue":"HIV Clinical Trials","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Medicine; Transforming growth factor; Human immunodeficiency virus (HIV); Immunology; Virology; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.144333365076009,"gpt":0.3613578829021454,"spread":0.2170245178261365,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.003783051,0.0005145236,0.002418217,0.0003263656,0.0002531915,0.00004587648,0.0001869597,0.003025764,0.002036876],"category_scores_gemma":[0.007660377,0.0004676435,0.0009023669,0.0001602752,0.0003279029,0.0001856055,0.0001569044,0.003441801,0.0008542298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001755394,"about_ca_system_score_gemma":0.0002310029,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007927782,"about_ca_topic_score_gemma":0.000003287838,"domain_scores_codex":[0.9915612,0.003354031,0.003641977,0.0008329302,0.0001210186,0.0004888749],"domain_scores_gemma":[0.9915828,0.004443551,0.003109249,0.0005622706,0.0002657077,0.00003640549],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001964773,0.000307333,0.002960512,0.0009547393,0.001794292,0.00009262103,0.00009130273,0.0000241069,0.553512,0.00001981024,0.4352668,0.00301174],"study_design_scores_gemma":[0.01576747,0.0006423566,0.1022654,0.001957785,0.00116287,0.0004723214,0.00006688216,0.000005670073,0.1030174,0.0001690892,0.7732369,0.001235842],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8980809,0.001306036,0.0006653021,0.06433342,0.03035245,0.002161393,0.001121599,0.0004658487,0.00151297],"genre_scores_gemma":[0.6493788,0.002694161,0.0002954654,0.2244002,0.01232658,0.0001977136,0.007777746,0.0004020957,0.1025273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4504946,"threshold_uncertainty_score":0.9999237,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2069363561","doi":"10.1310/b05e-tfvn-uj8l-mfhj","title":"Attenuated T-Lymphocyte Response to HIV Therapy in Individuals Receiving HMG-CoA Reductase Inhibitors","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Fibrate; Ritonavir; Nelfinavir; HMG-CoA reductase; Statin; Rosuvastatin; Atorvastatin; Internal medicine; Saquinavir; Pharmacology; Indinavir; Protease inhibitor (pharmacology); Integrase inhibitor; Viral load; Immunology; Reductase; Antiretroviral therapy; Human immunodeficiency virus (HIV)","retraction":null,"screen_n_in":null,"score":{"opus":0.1986185197320598,"gpt":0.4835371366619322,"spread":0.2849186169298724,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0215158,0.0003117623,0.00153747,0.0004511682,0.0001598997,0.00003730734,0.0001616916,0.0004320704,0.0005025737],"category_scores_gemma":[0.03658906,0.0002483471,0.0003591874,0.001104707,0.00009249104,0.00007907195,0.00003988677,0.0005215269,0.001735084],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003008971,"about_ca_system_score_gemma":0.0008986655,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003429963,"about_ca_topic_score_gemma":0.000004458593,"domain_scores_codex":[0.9887778,0.00622087,0.003254193,0.0007714197,0.0004028018,0.0005729111],"domain_scores_gemma":[0.9889164,0.008610926,0.0005828685,0.0009405333,0.0001850383,0.0007642393],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02836626,0.007513487,0.6977782,0.00007338047,0.0009715296,0.0003951338,0.002409861,0.00007226411,0.009046935,0.0004738093,0.138556,0.1143431],"study_design_scores_gemma":[0.07355297,0.003729723,0.4838428,0.001724327,0.0003385803,0.00009999137,0.00036845,0.00005667159,0.005311322,0.0009153688,0.4292287,0.0008310651],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9799179,0.0007434819,0.00004074243,0.01448813,0.0005654673,0.002683369,0.00009434704,0.0001193093,0.001347245],"genre_scores_gemma":[0.987408,0.00129603,0.004026791,0.003322445,0.0003672248,0.0003372241,0.0001110753,0.0000697797,0.0030614],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2906727,"threshold_uncertainty_score":0.9999969,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2094521579","doi":"10.1310/hct1206-313","title":"Effect of Baseline Characteristics on the Efficacy and Safety of Once-Daily Darunavir/ Ritonavir in HIV-1–Infected, Treatment-Naïve ARTEMIS Patients at Week 96","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa","funders":"ACT Government","keywords":"Medicine; Darunavir; Ritonavir; Coinfection; Internal medicine; Incidence (geometry); Adverse effect; Lopinavir; Hepatitis C; Gastroenterology; Human immunodeficiency virus (HIV); Viral load; Immunology; Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1316770868769122,"gpt":0.3890928780651015,"spread":0.2574157911881892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.005811241,0.000376435,0.002195968,0.0001187008,0.00006303688,0.0000064067,0.00011614,0.0002323628,0.0004208507],"category_scores_gemma":[0.01071612,0.000204413,0.0003977037,0.0001980004,0.0002599625,0.00003994015,0.00007767932,0.0002275582,0.0001513462],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001305146,"about_ca_system_score_gemma":0.0001058047,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002071581,"about_ca_topic_score_gemma":0.000007025908,"domain_scores_codex":[0.9937112,0.002573518,0.00259022,0.000475515,0.0003597878,0.0002897549],"domain_scores_gemma":[0.9794518,0.01878337,0.0009005039,0.0005413246,0.0001090846,0.000213898],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0281526,0.005703926,0.8866084,0.000106447,0.000641729,0.0000512882,0.0006173087,2.323515e-7,0.0002356266,0.00004951438,0.001193946,0.07663896],"study_design_scores_gemma":[0.06925373,0.01127573,0.8948661,0.001105,0.001515095,0.000004659779,0.00002779742,0.00006683436,0.01477023,0.00002147749,0.006790841,0.000302506],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951876,0.00006389252,0.000007158169,0.0005388972,0.00024146,0.002288436,0.0003631687,0.00002574312,0.001283632],"genre_scores_gemma":[0.9960886,0.000797338,0.0002635543,0.00007953891,0.0001708793,0.00007622677,0.0004076491,0.00003351665,0.002082744],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07633645,"threshold_uncertainty_score":0.9976171,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992656981","doi":"10.1310/hct1006-413","title":"A Systematic Review of the Quality of Trials Evaluating Biomedical HIV Prevention Interventions Shows That Many Lack Power","year":2009,"lang":"en","type":"review","venue":"HIV Clinical Trials","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; Public Health Ontario; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; McGill University; Mount Sinai Hospital; SickKids Foundation; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Medicine; Psychological intervention; Randomized controlled trial; Clinical trial; Systematic review; Human immunodeficiency virus (HIV); Intensive care medicine; MEDLINE; Family medicine; Internal medicine; Psychiatry","retraction":null,"screen_n_in":null,"score":{"opus":0.9678022509413752,"gpt":0.8037718717577813,"spread":0.1640303791835939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_broad","research_integrity"],"category_scores_codex":[0.6828751,0.0007422302,0.03666202,0.0003351791,0.00008607668,0.00004417999,0.001917984,0.00278802,0.002470357],"category_scores_gemma":[0.9398291,0.0003779204,0.03036847,0.001131299,0.001261699,0.00007359248,0.0007742996,0.005413595,0.0002123169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002722673,"about_ca_system_score_gemma":0.005252168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006633821,"about_ca_topic_score_gemma":0.000006329077,"domain_scores_codex":[0.6736715,0.2372185,0.07735446,0.001957883,0.008912222,0.0008854466],"domain_scores_gemma":[0.09455933,0.8319252,0.06112724,0.007870104,0.003460541,0.001057593],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001921498,0.001722908,0.00001040417,0.9297968,0.00250789,0.000003814887,0.00001416767,1.440493e-8,0.000001312294,0.00162712,0.006195877,0.05792752],"study_design_scores_gemma":[0.003171671,0.001218026,0.00002631265,0.9425944,0.02862231,0.00001373242,0.00002483649,0.000003797488,0.000001057076,0.004946718,0.01910775,0.0002693572],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000005332388,0.9713433,0.0006505836,0.002884278,0.001417976,0.021952,0.0005633612,0.00004368182,0.00113945],"genre_scores_gemma":[0.0000155494,0.9828736,0.001229743,0.0005569996,0.0007166053,0.0006829643,0.0002138074,0.00007771249,0.01363298],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.5947067,"threshold_uncertainty_score":0.9998673,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1982283413","doi":"10.1310/hct1306-301","title":"Design and Implementation of a Randomized Crossover Study of Valproic Acid and Antiretroviral Therapy to Reduce the HIV Reservoir","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"HIV Legal Network; AIDS Vancouver; University of British Columbia; Centre Hospitalier de l’Université de Montréal; Centre hospitalier universitaire de Québec; Ottawa Hospital; University of Ottawa; Royal Victoria Hospital; McGill University Health Centre; Université de Montréal; Royal Victoria Regional Health Centre","funders":"National Institute on Drug Abuse; Ontario HIV Treatment Network","keywords":"Medicine; Crossover study; Valproic Acid; Clinical study design; Clinical trial; Human immunodeficiency virus (HIV); Randomized controlled trial; Crossover; Research design; Oncology; Pharmacology; Internal medicine; Immunology; Epilepsy; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.2416036895497824,"gpt":0.5034676164749569,"spread":0.2618639269251745,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01915018,0.0001261729,0.001193078,0.0000609061,0.0001067013,0.00001462118,0.0001251347,0.0001053771,0.0002230669],"category_scores_gemma":[0.003468239,0.00006591606,0.0001645529,0.00009374944,0.000362237,0.00007069182,0.00009468443,0.0001471009,0.00004723957],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000007512673,"about_ca_system_score_gemma":0.00005572139,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001017655,"about_ca_topic_score_gemma":0.00000463992,"domain_scores_codex":[0.9889737,0.009195582,0.001271281,0.000213717,0.00007891261,0.0002668331],"domain_scores_gemma":[0.9904125,0.008772539,0.0004094565,0.0002711124,0.00007704453,0.00005736297],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5101156,0.003798299,0.2114118,0.00003320558,0.004814563,0.000002915543,0.01083198,0.000002368595,0.1814467,0.000240153,0.01012202,0.06718046],"study_design_scores_gemma":[0.7328468,0.008324944,0.1439779,0.00003341011,0.0005189131,0.00000751117,0.003460575,0.000002230496,0.1088395,0.0002318602,0.001553193,0.0002031787],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914649,0.003689063,0.0002143741,0.0004044508,0.0001544703,0.003971204,0.00007091105,0.000007908385,0.0000227069],"genre_scores_gemma":[0.9984493,0.0007645498,0.0002277166,0.0000441087,0.00005619856,0.0001904304,0.00002072571,0.000008328164,0.0002385889],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2227312,"threshold_uncertainty_score":0.6637108,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1963635957","doi":"10.1310/hct0902-73","title":"Efficacy and Safety of 48 Weeks of Enfuvirtide 180 mg Once-Daily Dosing Versus 90 mg Twice-Daily Dosing in HIV-Infected Patients","year":2008,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tolerability; Enfuvirtide; Dosing; Regimen; Adverse effect; Pharmacokinetics; Internal medicine; Pharmacology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1454580302820737,"gpt":0.408940599363976,"spread":0.2634825690819023,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035445,0.000373677,0.002409733,0.0002882575,0.000110051,0.00001312002,0.0001402253,0.0003360673,0.0001632918],"category_scores_gemma":[0.01298233,0.0003002981,0.0004208128,0.0004992679,0.0003840658,0.0001236658,0.0001225585,0.0004193795,0.00008420866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001366571,"about_ca_system_score_gemma":0.0003541474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004156774,"about_ca_topic_score_gemma":0.00001412235,"domain_scores_codex":[0.9933258,0.001232597,0.003770028,0.0006153128,0.000603981,0.0004522447],"domain_scores_gemma":[0.9892284,0.00863451,0.001126771,0.0004719672,0.0002149424,0.0003233996],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05294479,0.004326333,0.9012566,0.0001828308,0.0009740824,0.0001452189,0.001731596,0.00001018724,0.001909754,0.000101903,0.004523375,0.03189329],"study_design_scores_gemma":[0.1702597,0.001588254,0.8142516,0.001448585,0.0008889535,0.00000803657,0.0001238532,0.0001028866,0.003337037,0.00003930098,0.007508048,0.0004437754],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946424,0.0002913906,0.00006818557,0.0007472218,0.0006371714,0.001387357,0.00006214013,0.00005656443,0.002107613],"genre_scores_gemma":[0.9943104,0.0009501909,0.003194218,0.00009098261,0.0002662393,0.00001833788,0.0001689898,0.00004313164,0.0009574428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1173149,"threshold_uncertainty_score":0.9999449,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W2085670377","doi":"10.1310/hct1504-161","title":"Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial","year":2014,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McMaster University Medical Centre; University Health Network; Ottawa Hospital; Vancouver Infectious Diseases Centre; Université de Montréal; AIDS Vancouver; Concordia University; McGill University Health Centre; McGill University; HIV Legal Network; University of Toronto; Royal Victoria Hospital","funders":"","keywords":"Medicine; Ribavirin; Citalopram; Internal medicine; Placebo; Randomized controlled trial; Hepatitis C; Depression (economics); Pegylated interferon; Hepatitis C virus; Immunology; Antidepressant","retraction":null,"screen_n_in":null,"score":{"opus":0.2860303912486745,"gpt":0.5005123531631583,"spread":0.2144819619144839,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05034217,0.0003049953,0.003668023,0.0002985536,0.0001181115,0.00009113136,0.0002240993,0.0004347905,0.000265648],"category_scores_gemma":[0.1219629,0.0001774654,0.000827954,0.0002526069,0.000468772,0.0001735257,0.0001122731,0.0005941456,0.00001509358],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003647293,"about_ca_system_score_gemma":0.0003098058,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001032,"about_ca_topic_score_gemma":0.00009727455,"domain_scores_codex":[0.982429,0.01165405,0.004374792,0.0005532304,0.0005834055,0.0004055433],"domain_scores_gemma":[0.9100348,0.08704709,0.001839992,0.0004046239,0.0004618573,0.0002116048],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9677876,0.00065658,0.01243836,0.0000777953,0.0008369592,0.000003295778,0.0002712781,0.000007062826,0.001157907,0.00009451476,0.0001266766,0.01654198],"study_design_scores_gemma":[0.9782,0.002052714,0.001124438,0.0007416575,0.0005223498,0.000002060302,0.00003392293,0.01449199,0.002116107,0.0002921144,0.0002541114,0.0001685195],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9645075,0.0006747348,0.001701557,0.001074198,0.0004610124,0.03104509,0.00006272046,0.00004726218,0.0004259554],"genre_scores_gemma":[0.9926032,0.002164867,0.000547517,0.0001673094,0.0004642826,0.003733138,0.0001022339,0.00003821444,0.0001792747],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07539305,"threshold_uncertainty_score":0.9778726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068355743","doi":"10.1310/hct0905-314","title":"A Prospective Study of Body Fat Redistribution, Lipid, and Glucose Parameters in HIV-Infected Patients Initiating Combination Antiretroviral Therapy","year":2008,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University Medical Centre; University Health Network; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Lipodystrophy; Medicine; Prospective cohort study; Internal medicine; Triglyceride; Endocrinology; Antiretroviral therapy; Waist; Lipoatrophy; Diabetes mellitus; Anthropometry; Lipid profile; Stavudine; Metabolic syndrome; Insulin; Human immunodeficiency virus (HIV); Gastroenterology; Cholesterol; Body mass index; Viral load; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.1445983891358264,"gpt":0.4386299770869479,"spread":0.2940315879511215,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001789475,0.0001642974,0.001019161,0.0001571523,0.0001421058,0.000008651306,0.00005405587,0.0001671513,0.00001077434],"category_scores_gemma":[0.006808463,0.00013085,0.0001202611,0.000442841,0.0001203471,0.00009195157,0.000029706,0.0003062691,0.00001361914],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000101649,"about_ca_system_score_gemma":0.00009707432,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006519644,"about_ca_topic_score_gemma":0.0000034675,"domain_scores_codex":[0.9958665,0.00124907,0.002014771,0.0003911373,0.0002736975,0.0002048021],"domain_scores_gemma":[0.9963945,0.00207883,0.0007585079,0.0002827144,0.0003429677,0.0001424372],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001375046,0.00899134,0.9852213,0.0000151886,0.0001353993,0.00001000246,0.0005873822,9.418396e-7,0.00003355829,0.00008665543,0.0001776756,0.003365455],"study_design_scores_gemma":[0.04145885,0.007660115,0.9498472,0.0001196075,0.00009372412,0.000003066116,0.0001333327,0.0002401065,0.0001503629,0.0001761821,0.00002352514,0.00009390207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995851,0.00008674993,0.00005919747,0.0001633628,0.000140241,0.003421641,0.0000700833,0.00004294355,0.0001648019],"genre_scores_gemma":[0.9988254,0.0003704866,0.0002377352,0.00006576523,0.00006511953,0.0001335543,0.0002702594,0.00001468867,0.00001702336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04008381,"threshold_uncertainty_score":0.8150858,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1999280643","doi":"10.1310/hct0705-251","title":"Infection Rates in HIV-HCV Patients Treated with Interferon Are Similar to Those in HCV Mono-Infection and Not Related to Neutropenia","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Neutropenia; Human immunodeficiency virus (HIV); Interferon; Infection rate; Internal medicine; Immunology; Ribavirin; Hepatitis C virus; Virus; Surgery; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1741195540349859,"gpt":0.4748693181522344,"spread":0.3007497641172485,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004309651,0.0002558234,0.001241628,0.0005968647,0.00004816745,0.00005950791,0.00006638726,0.0003340284,0.0001106326],"category_scores_gemma":[0.008807352,0.0001971082,0.0001160207,0.0009474856,0.00006446541,0.0001623506,0.00009097324,0.0006114709,0.0002869023],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002518753,"about_ca_system_score_gemma":0.00007997693,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003124915,"about_ca_topic_score_gemma":0.005284388,"domain_scores_codex":[0.9946014,0.002089974,0.001903575,0.0006523181,0.0003486989,0.0004040107],"domain_scores_gemma":[0.9973239,0.001545083,0.0002694046,0.0003317483,0.000210653,0.0003192322],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007484408,0.0006400985,0.9713193,0.00003225123,0.000036754,0.00005437403,0.0000651471,0.000153662,0.0004929111,0.000006671893,0.002192353,0.01752213],"study_design_scores_gemma":[0.01289227,0.00335992,0.976871,0.0007091865,0.00005453052,0.000001170427,0.000007415549,0.0003948662,0.001384618,0.00002848087,0.004092536,0.0002039948],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943491,0.0000178168,0.00005096856,0.00154903,0.0001516019,0.002799406,0.00003611602,0.00007402737,0.0009718859],"genre_scores_gemma":[0.9980794,0.0002165561,0.0001917281,0.0004150972,0.0001521131,0.0001787038,0.00009784132,0.0000458681,0.0006226493],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01731813,"threshold_uncertainty_score":0.9995419,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2122378285","doi":"10.1310/hct0806-421","title":"Evaluation of Stool Frequency and Stool Form as Measures of HIV-Related Diarrhea","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"St. Michael's Hospital; University of Toronto; University Health Network; Mount Sinai Hospital; Health Sciences Centre; Sinai Health System; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences","funders":"University of Toronto; Innovative Research Group Project of the National Natural Science Foundation of China; University Health Network","keywords":"Diarrhea; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Gastroenterology; Prospective cohort study; Antiretroviral therapy; Correlation; Viral load; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.3488472668489003,"gpt":0.5262927517135569,"spread":0.1774454848646567,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03698162,0.0001588457,0.001178941,0.0001783445,0.00007148469,0.000004697927,0.00007953054,0.0003609783,0.0004129646],"category_scores_gemma":[0.0235774,0.0001204461,0.0002820099,0.000286315,0.0001756512,0.00006698668,0.00002317792,0.0002852675,0.0001173685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009347411,"about_ca_system_score_gemma":0.0005635076,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007430066,"about_ca_topic_score_gemma":0.00001750495,"domain_scores_codex":[0.9941494,0.001187861,0.003218294,0.0003291743,0.0008775145,0.0002377826],"domain_scores_gemma":[0.9926909,0.00436538,0.001117164,0.0005059043,0.001027822,0.0002927863],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.002962405,0.004231502,0.3032378,0.0003309085,0.00246001,0.00002163635,0.001012713,0.00001913998,0.003216099,0.01291452,0.003270045,0.6663232],"study_design_scores_gemma":[0.04505923,0.003234835,0.9050047,0.001164114,0.006761494,0.00004584981,0.0002155722,0.001026481,0.002632581,0.03132766,0.003179959,0.000347503],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.978819,0.002534817,0.0004805857,0.001187364,0.0002549937,0.002420012,0.00006938445,0.00004010593,0.01419378],"genre_scores_gemma":[0.9973902,0.0006335053,0.00133264,0.00009694308,0.0001141968,0.00004049675,0.00007547409,0.00001958757,0.0002969858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6659757,"threshold_uncertainty_score":0.9916301,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239380123","doi":"10.1310/hct1301-023","title":"High-Level Immunogenicity Is Achieved Vaccine With Adjuvanted Pandemic H1N1&lt;sub&gt;2009&lt;/sub&gt; and Improved With Booster Dosing in a Randomized Trial of HIV-Infected Adults","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Public Health Agency of Canada; University of British Columbia; Dalhousie University; University of Toronto; McGill University; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Immunogenicity; Seroconversion; Dosing; Booster dose; Booster (rocketry); Immunology; Live attenuated influenza vaccine; Influenza vaccine; Immunization; Internal medicine; Vaccination; Virology; Antigen; Human immunodeficiency virus (HIV)","retraction":null,"screen_n_in":null,"score":{"opus":0.1541682413321429,"gpt":0.4268660800435144,"spread":0.2726978387113715,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02612809,0.0007959441,0.007688664,0.0004687023,0.0001635593,0.00005165196,0.0002778321,0.0006505856,0.0001202125],"category_scores_gemma":[0.04398056,0.0004738016,0.0008377106,0.0007656524,0.00074079,0.0003637757,0.0003194169,0.001241518,0.00003568756],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001456655,"about_ca_system_score_gemma":0.0005085246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001676609,"about_ca_topic_score_gemma":0.0001718615,"domain_scores_codex":[0.9858701,0.005537793,0.005297688,0.0009706509,0.001068633,0.001255107],"domain_scores_gemma":[0.9766194,0.01876281,0.002155098,0.001026544,0.0008227251,0.0006134063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9097545,0.001482363,0.02400636,0.0002188887,0.002154717,0.00002034646,0.0005850928,0.000001256016,0.05560905,0.00001372669,0.0005155811,0.00563817],"study_design_scores_gemma":[0.9203411,0.003983899,0.05934005,0.001474912,0.001725547,0.00002768816,0.00006546975,0.0002690553,0.01189615,0.00002784426,0.0003035267,0.000544701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859465,0.002698019,0.000395147,0.0007248719,0.0003501477,0.009320019,0.0003414168,0.0001326296,0.0000912574],"genre_scores_gemma":[0.9923645,0.003025156,0.002017797,0.00065017,0.001123234,0.0004469199,0.00009617511,0.0001095096,0.0001665023],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04371291,"threshold_uncertainty_score":0.9997714,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2105543437","doi":"10.1179/1528433614z.0000000015","title":"Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054)","year":2015,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Regimen; Lamivudine; Adverse effect; Emtricitabine; Internal medicine; Viral load; Surgery; Gastroenterology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Virology; Chronic hepatitis","retraction":null,"screen_n_in":null,"score":{"opus":0.3198417514449129,"gpt":0.4775088242655605,"spread":0.1576670728206476,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008785741,0.0003757256,0.001679557,0.00009303346,0.0001337836,0.00006621402,0.0001587433,0.000280292,0.0000996471],"category_scores_gemma":[0.01522776,0.0001977812,0.0002384603,0.0002301981,0.0002106395,0.0001112336,0.0002019192,0.0003976243,0.0001182952],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000572587,"about_ca_system_score_gemma":0.0002873235,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004623542,"about_ca_topic_score_gemma":0.0001489699,"domain_scores_codex":[0.9922292,0.003839447,0.002098625,0.0009437777,0.0005005719,0.0003884168],"domain_scores_gemma":[0.9868096,0.0114951,0.0005291464,0.0006526523,0.00008343787,0.000430114],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1024359,0.01746647,0.5566903,0.00001252608,0.00367514,0.003795021,0.03709988,0.000003788911,0.0006918264,0.0001780741,0.1550396,0.1229115],"study_design_scores_gemma":[0.1596266,0.0107609,0.6970369,0.0009148138,0.002247023,0.00004175034,0.03765026,0.0002060519,0.002448427,0.001542999,0.08668858,0.0008356581],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691302,0.0005576324,0.000006642775,0.02325529,0.0002917892,0.002888165,0.0002363795,0.00005833516,0.003575638],"genre_scores_gemma":[0.9933165,0.0008954185,0.001276269,0.0006333952,0.0005302722,0.0001579061,0.0001828008,0.00002670606,0.002980675],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1403466,"threshold_uncertainty_score":0.9930674,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965528887","doi":"10.1310/q2l2-qvrk-4e01-c8f8","title":"Progression to AIDS or Death as Endpoints in HIV Clinical Trials","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"Styrelsen för Internationellt Utvecklingssamarbete","keywords":"Medicine; Regimen; Internal medicine; Clinical endpoint; Clinical trial; Cohort; Antiretroviral therapy; Human immunodeficiency virus (HIV); Protease inhibitor (pharmacology); Viral load; Oncology; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.5056012280870779,"gpt":0.6012395459815103,"spread":0.09563831789443245,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.08442882,0.0004148794,0.003759814,0.0002905414,0.0001699371,0.00006034383,0.0005808579,0.001148727,0.01040299],"category_scores_gemma":[0.1947978,0.0002467466,0.00124321,0.0004257962,0.0003063002,0.0001083474,0.0003208239,0.001147486,0.03894016],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008217888,"about_ca_system_score_gemma":0.0006091676,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004213096,"about_ca_topic_score_gemma":0.00005671917,"domain_scores_codex":[0.9576506,0.0332354,0.006690098,0.001145661,0.0002109744,0.001067266],"domain_scores_gemma":[0.9450092,0.05239106,0.0009719448,0.0009783648,0.0001458592,0.0005036102],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05336245,0.005437593,0.2584824,0.00001846467,0.001085008,0.0009951411,0.0001079119,0.000001553676,0.002686733,0.0005478979,0.08808012,0.5891947],"study_design_scores_gemma":[0.06634691,0.01242051,0.07841518,0.0005608127,0.000409151,0.0001437699,0.0001847594,0.000003922643,0.005566058,0.001557999,0.8336598,0.0007310815],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9731731,0.002184077,0.0005901358,0.006904993,0.003853504,0.005996388,0.0004890105,0.0002355766,0.00657318],"genre_scores_gemma":[0.9483769,0.005553393,0.00402192,0.00216159,0.001962858,0.0008609839,0.0007788482,0.00008825396,0.03619529],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7455797,"threshold_uncertainty_score":0.9999985,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2068181643","doi":"10.1310/hct0805-311","title":"An Estimate of the Proportion of Symptoms Reported in Self-Administered Questionnaires That Are Captured as Adverse Drug Events in an Observational Database","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; University Health Network","funders":"Ontario HIV Treatment Network","keywords":"Medicine; Interquartile range; Diarrhea; Nausea; Adverse effect; Cohort; Observational study; Cohort study; Pediatrics; Internal medicine","retraction":null,"screen_n_in":null,"score":{"opus":0.5661113770237269,"gpt":0.6173921826787941,"spread":0.05128080565506721,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01627257,0.000201524,0.0007540865,0.0001621279,0.00008136867,0.000003746683,0.0003355277,0.0003140167,0.0001604696],"category_scores_gemma":[0.003183277,0.0001577147,0.0002392429,0.0003946475,0.0001884971,0.0004593691,0.00005685352,0.0007320369,0.00001052361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007734051,"about_ca_system_score_gemma":0.0003877093,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007709548,"about_ca_topic_score_gemma":0.0005243372,"domain_scores_codex":[0.993148,0.003086301,0.002685819,0.0004178709,0.0003638814,0.0002981359],"domain_scores_gemma":[0.9949756,0.00200281,0.002154509,0.0004640714,0.0001854251,0.0002176241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002131276,0.002955098,0.9809415,0.00006146894,0.0001087057,0.00006183694,0.0003159336,0.001000161,0.01113434,0.0002357663,0.0002180768,0.0008358377],"study_design_scores_gemma":[0.005793002,0.00009993828,0.9641582,0.0001831974,0.0002465129,0.00001121782,0.0003135295,0.001911422,0.02503045,0.0005148603,0.001557383,0.0001802499],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960445,0.00005216238,0.00003548283,0.0005709936,0.001811884,0.001097547,0.0002416101,0.00004332277,0.000102481],"genre_scores_gemma":[0.9984947,0.00009564741,0.0001906068,0.0005196632,0.0003155886,0.00004430383,0.0002538992,0.00001641236,0.00006918939],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01678326,"threshold_uncertainty_score":0.6431417,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2143379599","doi":"10.1310/fgmf-y0ly-dmx8-371v","title":"Predictors of Long-Term Immunological Outcome in Rebounding Patients on Protease Inhibitor-Based HAART After Initial Successful Virologic Suppression: Implications for Timing to Switch","year":2003,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"McMaster University; Bayer Corporation","keywords":"Medicine; Viremia; Viral load; Internal medicine; Protease inhibitor (pharmacology); Univariate analysis; Gastroenterology; Reverse-transcriptase inhibitor; Immunology; Retrospective cohort study; Multivariate analysis; Area under the curve; Human immunodeficiency virus (HIV); Antiretroviral therapy","retraction":null,"screen_n_in":null,"score":{"opus":0.220466695654694,"gpt":0.4709658042581454,"spread":0.2504991086034514,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004336989,0.0002620461,0.001089022,0.0002301572,0.0001529401,0.00002343951,0.0002662027,0.0005375186,0.0005053266],"category_scores_gemma":[0.02002942,0.0001814318,0.0004310395,0.0001911517,0.0002479852,0.00006574876,0.00008580353,0.0004524481,0.0002769366],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008749859,"about_ca_system_score_gemma":0.0001564827,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006584123,"about_ca_topic_score_gemma":0.000007628474,"domain_scores_codex":[0.993585,0.003018141,0.002118612,0.0006137279,0.00009192454,0.0005726111],"domain_scores_gemma":[0.9924121,0.006413454,0.0004149887,0.0004952016,0.0001402365,0.0001239605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007178249,0.002479043,0.9819005,0.00003083731,0.0001306241,0.00001039451,0.0000284675,0.00000639202,0.003529632,0.00007124354,0.000484935,0.004149665],"study_design_scores_gemma":[0.0142689,0.003895369,0.963162,0.0001551367,0.00007972947,0.000001660923,0.00001121549,5.552803e-7,0.01640566,0.0001276144,0.001680809,0.0002113369],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934896,0.0001255618,0.0004158335,0.0006111028,0.0008172769,0.003676744,0.0006954551,0.00003926911,0.0001291857],"genre_scores_gemma":[0.9969977,0.00001261947,0.0002766559,0.0002420735,0.0000828488,0.001803169,0.0004245015,0.00001923239,0.0001412146],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01873851,"threshold_uncertainty_score":0.9882253,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2317708264","doi":"10.1310/hct1302-90","title":"Relationship of Chronic Hepatitis C Infection to Rates of AIDS-Defining Illnesses in a Canadian Cohort of HIV Seropositive Individuals Receiving Highly Active Antiretroviral Therapy","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"St. Michael's Hospital; University of Ottawa; Simon Fraser University; McGill University; McGill University Health Centre; Ontario HIV Treatment Network; Women's College Hospital; Maple Leaf Medical Clinic; Public Health Ontario; Canadian AIDS Treatment Information Exchange; St. Paul's Hospital; University of British Columbia; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Multicenter AIDS Cohort Study; Cohort; Internal medicine; Hepatitis C virus; Immunology; Rate ratio; Poisson regression; Hepatitis C; Cohort study; Relative risk; Viral disease; Virology; Human immunodeficiency virus (HIV); Sida; Confidence interval; Virus; Population; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.1866082505449775,"gpt":0.4777872682201085,"spread":0.291179017675131,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01433591,0.0001921557,0.001704603,0.0008200598,0.00006207472,0.00001097289,0.0001269868,0.0003401824,0.0002797848],"category_scores_gemma":[0.04859136,0.0001719098,0.0002863652,0.001049045,0.0002392622,0.0002821918,0.0000553719,0.0005061281,0.00004346858],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004063654,"about_ca_system_score_gemma":0.001533325,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1714165,"about_ca_topic_score_gemma":0.04314438,"domain_scores_codex":[0.9929216,0.00329887,0.002391296,0.0003111724,0.0005418127,0.0005352544],"domain_scores_gemma":[0.9872057,0.01070273,0.000835374,0.0003620436,0.0004254516,0.0004686507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004874437,0.0003001103,0.9690376,0.0000940423,0.0002326201,0.000003366187,0.0007488846,0.00001299595,0.001328348,0.000427825,0.0002301329,0.02709664],"study_design_scores_gemma":[0.002947207,0.001680387,0.9715293,0.0006774213,0.00009758494,0.000001390078,0.00005981814,0.00003163064,0.02228636,0.00006220466,0.0004871821,0.0001395027],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9957644,0.0003297558,0.00006835084,0.0003074506,0.0003437502,0.001596084,0.0003909559,0.00001546398,0.001183795],"genre_scores_gemma":[0.9976231,0.001179365,0.0005780067,0.00006645024,0.0002740174,0.00008104281,0.0001044627,0.00003403197,0.00005947296],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1282722,"threshold_uncertainty_score":0.9743158,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971304024","doi":"10.1310/hct0801-36","title":"Virologic and Immunologic Impact and Durability of Enfuvirtide-Based Antiretroviral Therapy in HIV-Infected Treatment-Experienced Patients in a Clinical Setting","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; St. Michael's Hospital; Maple Leaf Medical Clinic","funders":"Canadian Institutes of Health Research","keywords":"Enfuvirtide; Medicine; Interquartile range; Viral load; Discontinuation; Internal medicine; Regimen; Hazard ratio; Retrospective cohort study; Adverse effect; Salvage therapy; Gastroenterology; Human immunodeficiency virus (HIV); Confidence interval; Immunology; Chemotherapy","retraction":null,"screen_n_in":null,"score":{"opus":0.1303890675655805,"gpt":0.4729908189783467,"spread":0.3426017514127663,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01200588,0.0003413438,0.002166146,0.0002607074,0.00004675919,0.00001604749,0.00007815724,0.0004134084,0.00007485234],"category_scores_gemma":[0.012205,0.0002097056,0.0004273529,0.0003586247,0.0004826316,0.00008270509,0.00004747284,0.0003407327,0.000007847741],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001555762,"about_ca_system_score_gemma":0.0002251331,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006895605,"about_ca_topic_score_gemma":0.00003602057,"domain_scores_codex":[0.9928029,0.002182675,0.003655958,0.0006741025,0.0002259423,0.0004584587],"domain_scores_gemma":[0.9888095,0.009808045,0.0007380227,0.0003488445,0.00007623946,0.0002193218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008532721,0.003375471,0.9005891,0.00001252494,0.0001298671,0.0000566044,0.000243243,7.870959e-7,0.0003839655,0.000004465697,0.00001230593,0.08665892],"study_design_scores_gemma":[0.04351513,0.007000949,0.9480056,0.00009193512,0.00006609109,0.000002199871,0.00009720564,0.0001085036,0.000817581,0.00006994664,0.00005593037,0.0001689588],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972648,0.0003262053,0.00001722011,0.0003828452,0.0001124313,0.001745982,0.00002683559,0.0000399244,0.00008373555],"genre_scores_gemma":[0.9976645,0.0009721157,0.000997902,0.0001294611,0.00005967187,0.00003911314,0.00006937042,0.0000157233,0.00005210895],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08648997,"threshold_uncertainty_score":0.9961156,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2023936662","doi":"10.1310/hct1306-357","title":"Physician Attitudes Regarding Pregnancy, Fertility Care, and Assisted Reproductive Technologies for HIV-Infected Individuals and Couples","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Women's College Hospital; University of British Columbia Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Fertility; Medicine; Assisted reproductive technology; Family medicine; Pregnancy; Population; Logistic regression; Reproductive medicine; Reproductive health; Fertility clinic; Gynecology; Infertility; Environmental health","retraction":null,"screen_n_in":null,"score":{"opus":0.2701846422825666,"gpt":0.4840508541485525,"spread":0.2138662118659859,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.006614894,0.0002968488,0.001763034,0.0001581072,0.0002350856,0.00004037104,0.0001225568,0.0005101487,0.000003484113],"category_scores_gemma":[0.09115025,0.0002142323,0.0002473296,0.0002676386,0.0008717887,0.0002272643,0.0002301363,0.0004768352,0.000005965003],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005458288,"about_ca_system_score_gemma":0.000102428,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005889871,"about_ca_topic_score_gemma":0.000001607687,"domain_scores_codex":[0.9962835,0.0004926407,0.001409623,0.001033879,0.0002260575,0.0005543285],"domain_scores_gemma":[0.9935668,0.004258164,0.0006739692,0.0009763713,0.0003524161,0.0001722849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007430293,0.0003520137,0.7484902,0.0006778885,0.0002602896,0.000001624186,0.0001282049,5.955427e-8,0.0009031668,0.000782355,0.001086679,0.2465746],"study_design_scores_gemma":[0.004615536,0.000901536,0.9662349,0.0006920231,0.0005184682,0.00001279985,0.001170328,0.000003392939,0.01059725,0.002242821,0.01273973,0.0002712344],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9507594,0.03828725,0.0002684207,0.004425223,0.0004896603,0.004051219,0.0001441411,0.001050201,0.0005245225],"genre_scores_gemma":[0.9867221,0.002790585,0.009279747,0.0001079013,0.0005488793,0.0003835511,0.00005263671,0.00003079257,0.00008377242],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2463033,"threshold_uncertainty_score":0.9165054,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097226982","doi":"10.1310/hct1206-323","title":"Four-Year Follow-Up of Polyalkylimide Gel Use for the Treatment of HIV-Associated Lipoatrophy","year":2011,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Dermatological and COVID-19 studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canadians Living with HIV; University of Toronto; University Health Network; St. Michael's Hospital; Maple Leaf Medical Clinic; Women's College Hospital","funders":"","keywords":"Medicine; Anxiety; Depression (economics); Randomized controlled trial; Quality of life (healthcare); Internal medicine; Lipoatrophy; Human immunodeficiency virus (HIV); Patient satisfaction; Physical therapy; Surgery; Viral load; Antiretroviral therapy; Psychiatry; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.5745653611812509,"gpt":0.4586381917043282,"spread":0.1159271694769227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.001995714,0.0001931551,0.001941159,0.00004170473,0.00007220473,0.00000581314,0.0001409692,0.0002088812,0.0001751872],"category_scores_gemma":[0.01886131,0.00009372795,0.001488002,0.0001292652,0.000295494,0.00003121765,0.00003472688,0.00009608334,0.00003620317],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002513594,"about_ca_system_score_gemma":0.00008148768,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006373493,"about_ca_topic_score_gemma":0.00001112921,"domain_scores_codex":[0.996766,0.0005711127,0.001885625,0.0002764752,0.0002430921,0.0002576881],"domain_scores_gemma":[0.9826,0.01584242,0.0007894354,0.0004169307,0.0002258618,0.0001253649],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0401311,0.01052203,0.8661007,0.0002118954,0.008748658,0.00006382607,0.002003008,0.00000248101,0.000842052,0.002231256,0.04178886,0.02735414],"study_design_scores_gemma":[0.09755395,0.01931287,0.766938,0.0003519298,0.009904089,0.00000886053,0.001251513,0.0001538344,0.00879708,0.006492876,0.08867841,0.0005565709],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922594,0.0006951653,0.000347585,0.002719709,0.0008689154,0.001893369,0.0003340277,0.00005978569,0.0008219804],"genre_scores_gemma":[0.9940589,0.001931994,0.0006729574,0.0006904884,0.0003036397,0.0001198655,0.0000178362,0.00001911159,0.002185178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09916269,"threshold_uncertainty_score":0.9894032,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2020067315","doi":"10.1310/95ve-a6kj-wrq0-1f8y","title":"Mild to Moderate Symptoms Do Not Correlate with Lactate Levels in HIV-Positive Patients on Nucleoside Reverse Transcriptase Inhibitors","year":2006,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Ontario HIV Treatment Network","keywords":"Medicine; Reverse transcriptase; Nucleoside Reverse Transcriptase Inhibitor; Human immunodeficiency virus (HIV); Nucleoside; Reverse-transcriptase inhibitor; Pharmacology; Internal medicine; Virology; Antiretroviral therapy; Viral load; RNA; Biochemistry","retraction":null,"screen_n_in":null,"score":{"opus":0.1136922117058813,"gpt":0.4102275988494202,"spread":0.2965353871435389,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002018766,0.0003603457,0.001379684,0.0002645421,0.0001515318,0.00003580493,0.0001084822,0.0003131653,0.0001106103],"category_scores_gemma":[0.0008583135,0.0002649182,0.0003005191,0.0004491561,0.00009277713,0.0001024582,0.0000229716,0.0006233592,0.001148432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002069649,"about_ca_system_score_gemma":0.0001771044,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002124271,"about_ca_topic_score_gemma":0.00003730122,"domain_scores_codex":[0.994904,0.00094771,0.002423396,0.0007771517,0.0004389741,0.0005087866],"domain_scores_gemma":[0.9965748,0.001720736,0.0004642831,0.0005287109,0.000209268,0.0005022174],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.09257452,0.02688053,0.6962469,0.0002619267,0.001435687,0.001107297,0.00210377,0.004136108,0.0006456007,0.003448373,0.124419,0.04674025],"study_design_scores_gemma":[0.05448795,0.004984672,0.926831,0.00281267,0.0007001305,0.000008597691,0.00004506129,0.0006532231,0.0006709229,0.0003718283,0.007839524,0.0005944356],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867869,0.00004116016,0.0002399668,0.005707804,0.0003993357,0.003112911,0.0007984776,0.0000842977,0.002829137],"genre_scores_gemma":[0.9927009,0.00004345451,0.00116797,0.00358939,0.0002288604,0.0001599163,0.0003030912,0.00006073252,0.001745712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2305841,"threshold_uncertainty_score":0.9999803,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981322336","doi":"10.1310/b45n-4xhb-53lu-jax9","title":"Selected Topics from the 38th Annual Meeting of the Infectious Diseases Society of America, September 7-10, 2000, New Orleans, Louisiana and Selected Topics from the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 17-20, 2000, Toronto, Ontario, Canada","year":2001,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"Antibiotic Resistance in Bacteria","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Gerontology; Antimicrobial; Library science; Microbiology","retraction":null,"screen_n_in":null,"score":{"opus":0.03259492114428208,"gpt":0.3132397287706411,"spread":0.280644807626359,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000521117,0.0002378772,0.0005884444,0.000004210063,0.0001422455,0.00005225632,0.0004125957,0.0001912114,0.0005323885],"category_scores_gemma":[0.001002292,0.0001367891,0.0001841528,0.0001405901,0.0004602916,0.0000133308,0.0001607064,0.0002056538,7.690311e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008622577,"about_ca_system_score_gemma":0.00147034,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2163191,"about_ca_topic_score_gemma":0.5964903,"domain_scores_codex":[0.9974452,0.0007226072,0.0008645672,0.0004777384,0.0002346217,0.0002553013],"domain_scores_gemma":[0.9977534,0.0008027799,0.0006366986,0.0005007195,0.0001962315,0.0001102086],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0003957264,0.00008965311,0.5454426,0.000007081481,0.0003078518,9.299944e-7,0.0004489368,0.00001002988,0.005065763,0.000001700771,0.4458822,0.002347516],"study_design_scores_gemma":[0.00224216,0.0002164829,0.728587,0.0001619138,0.0002045772,0.000003081335,0.0003453887,0.0001016404,0.002388461,0.00002909154,0.2654473,0.0002728477],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9958412,0.0003603417,0.0001336081,0.001650298,0.0003445995,0.0004326187,0.0005626134,0.000007935013,0.0006668104],"genre_scores_gemma":[0.9835374,0.001074976,0.0005049075,0.004168015,0.0009904982,0.000003129673,0.000168703,0.00002496104,0.009527346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3801712,"threshold_uncertainty_score":0.7888995,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111884657","doi":"10.1310/hct1306-335","title":"Abacavir/Lamivudine Fixed-Dose Combination With Ritonavir-Boosted Darunavir: A Safe and Efficacious Regimen for HIV Therapy","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Abacavir; Darunavir; Emtricitabine; Lamivudine; Regimen; Ritonavir; Internal medicine; Gastroenterology; Viral load; Creatinine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology; Hepatitis B virus; Virus","retraction":null,"screen_n_in":null,"score":{"opus":0.1741915860826942,"gpt":0.4424751159049179,"spread":0.2682835298222236,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006070302,0.000356882,0.00150789,0.0001179635,0.0001587894,0.00003761979,0.00009725193,0.0002868056,0.0001303721],"category_scores_gemma":[0.002235597,0.0002303453,0.0002998275,0.000187325,0.0001770894,0.0001596199,0.00004181657,0.000266877,0.0001520172],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006916757,"about_ca_system_score_gemma":0.0001410285,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002868018,"about_ca_topic_score_gemma":0.000001979526,"domain_scores_codex":[0.996468,0.0006923368,0.001468067,0.0005023481,0.0003834733,0.0004857648],"domain_scores_gemma":[0.9936095,0.004845423,0.0005065991,0.000418772,0.0001560297,0.0004636967],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.04579486,0.01295683,0.3058602,0.0002438722,0.00435702,0.00009833081,0.001978518,0.000001422363,0.00148606,0.004061403,0.07940871,0.5437528],"study_design_scores_gemma":[0.2044169,0.005160019,0.252421,0.00056836,0.002139259,0.0001226286,0.0003375295,0.0002187961,0.003435031,0.0006641162,0.529419,0.001097385],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9561151,0.002858878,0.0009339955,0.02655252,0.0007419895,0.007729524,0.0001644087,0.0002746171,0.004628974],"genre_scores_gemma":[0.9625205,0.001421938,0.009993752,0.0008413733,0.001165745,0.0004968923,0.0007919578,0.00008994035,0.02267784],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5426554,"threshold_uncertainty_score":0.9393209,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2037740736","doi":"10.1310/hct1304-179","title":"A Pilot, Prospective, Open-Label Simplification Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Once-Daily Lopinavir-Ritonavir Monotherapy in HIV-HCV Coinfected Patients: The MONOCO Study","year":2012,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; University of British Columbia; Ottawa Hospital; Abbott (Canada); University of Ottawa","funders":"Ontario HIV Treatment Network; Abbott Laboratories","keywords":"Medicine; Ritonavir; Lopinavir; Adverse effect; Pharmacokinetics; Prospective cohort study; Lopinavir/ritonavir; Internal medicine; Viral load; Pharmacology; Gastroenterology; Human immunodeficiency virus (HIV); Antiretroviral therapy; Immunology","retraction":null,"screen_n_in":null,"score":{"opus":0.2869704247703874,"gpt":0.5185631127525557,"spread":0.2315926879821684,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01368224,0.0003538952,0.001413547,0.0001116318,0.0001783129,0.00006125656,0.0004174004,0.00006139306,0.00006172153],"category_scores_gemma":[0.004106241,0.0001860423,0.0000931865,0.000606697,0.0001495054,0.0001122232,0.0002566243,0.0003796385,0.00008262584],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001314661,"about_ca_system_score_gemma":0.0001612567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006904631,"about_ca_topic_score_gemma":0.00005313669,"domain_scores_codex":[0.9918846,0.004068442,0.002484872,0.0005699754,0.0006101897,0.000381894],"domain_scores_gemma":[0.9924791,0.005712644,0.0005431353,0.0007359217,0.0002962397,0.0002330003],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01250022,0.04787905,0.9018008,0.00001227248,0.0007750353,0.000003070793,0.006284233,0.000004929896,0.0001336641,0.00004504228,0.001656683,0.02890498],"study_design_scores_gemma":[0.09507014,0.006025149,0.8935567,0.00009046992,0.0008022522,8.198971e-7,0.00113972,0.00007779877,0.0001183437,0.00003718128,0.002882065,0.0001993203],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.971732,0.000191452,0.00005488974,0.003267955,0.0003183443,0.02396548,0.00004483271,0.00003472205,0.0003903173],"genre_scores_gemma":[0.9968289,0.0002468245,0.0003884437,0.0004092228,0.000255409,0.001030305,0.00003970823,0.00004349657,0.0007577568],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08256991,"threshold_uncertainty_score":0.7586586,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1996104688","doi":"10.1310/hct0805-259","title":"Randomized Controlled Trial of Once-Daily Tenofovir, Lamivudine, and Lopinavir/Ritonavir Versus Remaining on the Same Regimen in Virologically Suppressed HIV-Infected Patients on Their First PI-Containing HAART Regimen","year":2007,"lang":"en","type":"article","venue":"HIV Clinical Trials","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta; McGill University; Centre Hospitalier de l’Université de Montréal; Centre hospitalier de l'Université Laval; GDI Integrated Facility Services (Canada); St. Michael's Hospital; Western University; McMaster University Medical Centre; University of British Columbia; Abbott (Canada); University of Toronto","funders":"Abbott Canada; Gilead Sciences","keywords":"Medicine; Regimen; Lopinavir; Lamivudine; Ritonavir; Adverse effect; Discontinuation; Randomized controlled trial; Internal medicine; Lopinavir/ritonavir; Clinical endpoint; Viral load; Gastroenterology; Human immunodeficiency virus (HIV); Immunology; Virus; Antiretroviral therapy; Hepatitis B virus","retraction":null,"screen_n_in":null,"score":{"opus":0.1190843410683194,"gpt":0.38938264742991,"spread":0.2702983063615906,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03296312,0.0006097481,0.005994472,0.0003036834,0.000195648,0.00004852385,0.000265885,0.0005245082,0.0001348475],"category_scores_gemma":[0.06607142,0.0003146428,0.001117104,0.0003342832,0.0005098413,0.0000809005,0.0001171015,0.0007867769,0.00005195786],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001531975,"about_ca_system_score_gemma":0.0002134673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001709585,"about_ca_topic_score_gemma":0.0000317694,"domain_scores_codex":[0.9881805,0.004824485,0.004693067,0.0008565412,0.00078401,0.0006614622],"domain_scores_gemma":[0.891571,0.1052655,0.001936217,0.0007190862,0.0002101551,0.0002980032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.982793,0.002242021,0.008449757,0.00001652922,0.001281933,0.0000714828,0.0005753332,0.000005379403,0.00004882056,0.001096385,0.00131868,0.002100644],"study_design_scores_gemma":[0.9794906,0.005935324,0.009272313,0.0007025262,0.0007242008,0.000001396491,0.0002219646,0.0001485909,0.0002467416,0.0002693556,0.002678955,0.0003080464],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9701397,0.00009575516,0.00003704436,0.009058801,0.0008268261,0.01110796,0.00002809175,0.00009283501,0.008612956],"genre_scores_gemma":[0.9951258,0.0005008712,0.0004656368,0.0006998472,0.0005976619,0.0005263386,0.0001295676,0.0000510509,0.001903226],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.100441,"threshold_uncertainty_score":0.9999306,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}